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ABSTRACT 
Testicular development and function are complex processes that involve 
synchronization of the proliferation, apoptosis, and differentiation of specific 
somatic and germ cells to ensure lifelong fertility. Dysregulation of the signaling 
pathways or molecular mechanisms underlying these biological events often causes 
male infertility. With the increase observed in male fertility disorders worldwide, it 
is important to understand the origin of these conditions to be able to develop 
therapeutic strategies to alleviate or cure them in the future. The aim of this thesis is 
to describe the function of specific proteins in testicular development and function.  
Upstream stimulatory factor 1 (USF1) is a transcription factor that plays multiple 
roles in biological systems. In the testis, USF1 is reported to be expressed in Sertoli 
cells (SCs) and to bind specific genes during the differentiation of SCs. However, it 
remains elusive whether USF1 plays a role during spermatogenesis. Retinoblastoma 
protein (RB) and its associated E2F3 transcription factor are the regulators of various 
cellular events, such as mitosis, apoptosis, meiosis, and differentiation. We have 
previously shown that RB and E2F3 regulate adult SC function in the testis; 
however, the mechanism underlying this regulatory process is still unclear.  
Plasmalemma vesicle-associated protein is an endothelial-cell-specific membrane 
protein that is expressed in stomatal and fenestral diaphragms of a subset of 
endothelial cells. This protein regulates vascular permeability, leukocyte migration, 
and angiogenesis in different tissues; however, its role in the function of the testis 
has not yet been elucidated. 
Overall, this thesis comprises four studies. In the first study, a flow-cytometry-
based method is developed to allow the rapid cell composition screening of fresh and 
cultured testicular tissues. In the second study, USF1 was shown to be expressed in 
spermatogonial stem cells, where it regulates the balance between spermatogonial 
stem cell self-renewal and differentiation. In the third study, the role of E2F3 during 
testicular development and the interaction between E2F3 and RB to maintain adult 
SC function were investigated. In the last study, the importance of plasmalemma 
vesicle-associated protein is revealed in the endocrine regulation of the testis. 
KEYWORDS: flow cytometry, USF1, spermatogonial stem cell, RB, E2F3, Sertoli 
cell, PLVAP   
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TIIVISTELMÄ 
Kiveksen kehitys ja siittiötuotanto ovat monimutkaisia ja tarkoin säädeltyjä 
prosesseja. Somaattisten solujen ja itusolujen oikea-aikainen jakautuminen, solu-
kuolema ja erilaistuminen ovat edellytyksenä miesten elinikäiselle hedelmälli-
syydelle. Miesten hedelmällisyyden häiriöt ovat lisääntyneet maailmanlaajuisesti, 
minkä vuoksi on tärkeää ymmärtää niiden syntyyn vaikuttavia molekulaarisia ja 
solutason mekanismeja, jotta tulevaisuudessa voidaan kehittää hoitoja niiden 
lievittämiseksi ja parantamiseksi. 
‘Upstream stimulatory factor 1 (USF1)’ on transkriptiotekijä, jolla on useita teh-
täviä eri kudoksissa. Kiveksessä sitä tiedetään tuotettavan Sertolin soluissa, joissa se 
niiden erilaistuessa sitoutuu useiden geenien säätelyalueille. On kuitenkin epäselvää, 
mikä on USF1:n merkitys hiiren siittiötuotannossa. Retinoblastoomaproteiini (RB) 
ja siihen liittyvä transkriptiotekijä E2F3 säätelevät useita solun tapahtumia, kuten 
jakautumista, solukuolemaa, meioosia ja erilaistumista. Olemme aiemmin 
osoittaneet, että kiveksessä RB yhdessä E2F3:n kanssa säätelee Sertolin solujen 
toimintaa, mutta taustalla vaikuttavaa säätelymekanismia ei tunneta. ‘Plasmalemma 
vesicle-associated protein’ (PLVAP) on soluspesifinen endoteliaalinen kalvopro-
teiini, joka ilmentyy aukkoisissa ja ikkunallisissa kalvoissa osassa endoteelisoluja. 
Se säätelee verisuonten läpäisevyyttä, valkosolujen läpäisyä ja verisuonten muodos-
tusta eri kudoksissa, mutta kiveksessä sen tehtävää ei ole vielä tutkittu. 
Tämä väitöskirja koostuu neljästä eri tutkimuksesta: virtaussytometrisestä 
menetelmästä ja kolmesta muusta osatyöstä, joissa tutkimme USF1:n, RB/E2F3-
vuorovaikutuksen ja PLVAP:n merkitystä kiveksen kehityksessä ja toiminnassa eri 
hiirimalleilla. Virtaussytometrinen menetelmä mahdollistaa nopean solukoostumuk-
sen selvityksen tuoreesta tai viljellystä kiveskudoksesta. Toisessa osatyössä 
osoitettiin USF1:n ilmentyvän myös ituradan kantasoluissa, joissa se säätelee 
kantasolujen uusiutumisen ja erilaistumisen välistä tasapainoa. Kolmannessa osa-
työssä tutkittiin E2F3:n merkitystä kiveksen kehityksessä ja sen vuorovaikutusta 
RB:n kanssa aikuisen hiiren Sertoli solujen toiminnan ylläpitämiseksi. Väitöskirjan 
viimeinen osatyö osoitti PLVAP:n  osallistuvan kiveksen kehityksen ja toiminnan 
hormonaaliseen säätelyyn. 
AVAINSANAT: virtaussytometria, USF1, ituradan kantasolu, RB, E2F3, Sertolin 
solu, PLVAP 
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Abbreviations 
1C haploid amount of DNA 
2C diploid amount of DNA 
4C tetraploid amount of DNA 
Aal type A-aligned spermatogonia 
Apr type A-paired spermatogonia 
ALCs adult Leydig cells 
AMH anti-Müllerian hormone 
ANOVA analysis of variance 
AR androgen receptor protein 
As type A-single spermatogonia 
Aundiff undifferentiated spermatogonia 
B type B spermatogonia 
BMP bone morphometric proteins 
BSA bovine serum albumin 
BTB blood-testis barrier 
CDK cyclin-dependent kinase 
CO2 carbon dioxide 
DAPI 4´, 6-diamidino-2-phenylindole 
DMEM Dulbecco´s modified eagle medium 
DNA deoxyribonucleic acid 
DNase deoxyribonuclease 
dpc days post coitum 
dpp days post partum 
DSB double-strand break 
E2F E2 promoter targeting factor 
E2F3a E2F transcription factor 3 isoform a  
E2F3b E2F transcription factor 3 isoform b 
FACS fluorescence-activated cell sorting 
FBS fetal bovine serum 
FOXL2 Forkhead box protein L2 
FLCs fetal Leydig cells 
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FSH follicle-stimulating hormone 
G1 Gap 1 phase of the cell cycle 
G0 Gap zero phase of the cell cycle 
GATA4 GATA binding protein 4 
GDNF glial cell line derived neurotrophic factor 
hCG human chorionic gonadotropin 
IF immunofluorescence 
IHC immunohistochemistry 
LH luteinizing hormone 
mRNA messenger RNA 
p107 retinoblastoma-like 1 
p130 retinoblastoma-like 2 
PCR polymerase chain reaction 
PFA paraformaldehyde 
PGCs primordial germ cells 
PLVAP plasmalemma vesicle-associated protein 
PLZF promyelocytic leukaemia zinc finger protein 
pRb retinoblastoma protein 
PTM peritubular myoid cells 
qRT-PCR quantitative RT-PCR 
RA retinoic acid 
RB retinoblastoma protein family 
RNA ribonucleic acid 
RT room temperature 
SC-Rb-/-E2f3-/- Sertoli cell-specific knockout of Rb and knockout of E2f3 
SC-Rb-/-E2f3+/- Sertoli cell-specific knockout of Rb and haploinsufficiency of 
E2f3 
SC-Rb-/-E2f3+/+ Sertoli cell-specific knockout of Rb 
SCs Sertoli cells 
shRNA short hairpin RNA 
SMA smooth muscle actin 
SOX9 SRY (sex determining region-Y) –box 9 
SRY sex determining region of chromosome Y 
SSCs spermatogonial stem cells 
STRA8 stimulated by retinoic acid gene 8 
TUNEL terminal deoxynucleotidyl transferase dUTP nick end labeling 
Usf1 upstream stimulatory factor 1  
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1 Introduction 
Infertility is a predominant condition that affects around 70 million people 
worldwide (around 0.9% of the whole population) 1. According to the World Health 
Organization, 9% of couples worldwide struggle with fertility issues, with nearly 
50% of the factors accounting for male defects 2. The causes of male defects such as 
decreased sperm count or testicular dysfunction vary from chromosomal 
abnormalities to developmental alterations, lifestyle, endocrine disruptors, medical 
illnesses, and medications. Moreover, around 30% of the male infertility cases 
remain idiopathic 3. 
Spermatogenesis (i.e., the production of spermatozoa) involves the proliferation, 
apoptosis, and differentiation of different somatic and germ cells in the seminiferous 
epithelium and interstitial space. This process is generally regulated by endocrine 
and autocrine/paracrine factors, which also include specific transcription factors. 
In this thesis, we selected three important proteins that have been reported to 
play a role in different biological functions and have been indicated as a potential 
target for some abnormal conditions. However, very few studies have been 
performed on the reproductive function of these proteins. Therefore, using different 
mouse models, we revealed their role in testicular development and function. 
Upstream stimulatory factor 1 (USF1) is a ubiquitous transcription factor that has 
been shown to regulate multiple biological roles, such as synaptic plasticity, blood 
pressure, and glucose and lipid metabolism 4–6. Moreover, as Usf1-deficient mice fed 
a high-fat diet (HFD) were found to exhibit a beneficial lipid profile, it has been 
suggested that USF1 can act as a potential therapeutic target for cardiometabolic 
diseases. However, the effects of Usf1 deletion on male fertility have not yet been 
investigated. Retinoblastoma protein (RB) is a tumor suppressor protein that has 
been largely reported to control cell cycle, apoptosis, and differentiation 7. We have 
previously reported that RB controls the function of Sertoli cells (SCs) in the adult 
testis 8. Notably, Rb deficiency, specifically in SCs, compromises the maturation of 
SCs, impairing spermatogenesis. However, the molecular mechanism underlying RB 
role remains unknown. Plasmalemma vesicle-associated protein (PLVAP) is a 
transmembrane protein expressed in fenestrated vascular endothelia. This protein 
regulates vascular permeability, leukocyte migration, angiogenesis, and the seeding 
Introduction 
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of fetal liver-derived macrophages to different tissues 9,10. It has been reported that 
Plvap-deficient mice exhibit barrier function and permeability failure, leading to the 
selective loss of plasma proteins. As the testicular vasculature consists of fenestrated 
endothelia, it is important to know the function of PLVAP in testicular development 
and function. 
In the studies performed in this thesis, different mouse lines were used to reveal 
the important roles of the above-mentioned transcription factors in testicular 
development and function. Our data show that USF1 plays a critical role in the 
maintenance of spermatogonial stem cell (SSC) self-renewal and differentiation, that 
the RB/E2F3 interplay maintains adult SCs in a quiescent state, and that PLVAP 
plays a role in the endocrine regulation of the testis. Moreover, we developed a flow-
cytometry-based method to study rodent testicular composition using intracellular 
fluorescent antibodies and DNA staining. 
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2 Review of the Literature 
The testis is a paired endocrine and exocrine organ that assures the reproductive 
capacity and perpetuation of mammals. The principal functions of the testis are the 
production of androgens and the production of sperm. The following is a detailed 
description of testis development and function exclusively in mice, with few 
examples from human and rat. 
2.1 Testicular development  
Generally, the testis originates in the bipotential genital ridges, which are formed by 
the proliferation of the coelomic epithelium at 9 dpc (days post coitum) in mice or 
28 dpc in humans during embryonic development 11,12. At 10 dpc in mice,  supporting 
cells, steroidogenic cells, and primordial germ cells (PGCs) develop, which originate 
from the yolk sac 13. 
2.1.1 Male sex determination and fetal testicular development 
Male sex determination includes the activation and suppression of specific genes for 
the organization and differentiation of the gonadal primordium (Figure 1). At 10–
10.5 dpc in mice and 42 dpc in humans 14, a subset of supporting cells in the XY 
genital ridges transiently express the SRY gene 15,16. These supporting cells engulf 
the PGCs, which then become gonocytes and form the sex cords. These supporting 
cells then become pre-SCs. The expression of SRY induces the expression of Sox9 
in mouse pre-SCs at 11.5 dpc, supported by positive-feedback loops with fibroblast 
growth factor 9 (FGF9), prostaglandin D2, and SOX9 itself. At the same time, these 
positive-feedback loops suppress the signaling of Wnt, Rspo1, and Foxl2, which are 
inducers of ovarian development 17.  
When Sox9 is upregulated, the mouse testis cord continues developing, including 
the shortening and thickening of the gonad until 14.4 dpc, at which loop-like 
structures are formed 18. Other supporting and steroidogenic cells that are among and 
immediately juxtaposed at the periphery of the developing testis cords become fetal 
Leydig (FLCs) and peritubular myoid (PTMs) cells, respectively. 
Review of the Literature 
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After the formation of the testis cords, masculinization of the fetus is promoted 
by the SCs and Leydig cells. Notably, SCs secrete anti-Müllerian hormone (AMH), 
which induces the regression of the Müllerian ducts 19, and support FLCs to produce 
testosterone for the development of the male reproductive tract and external genitalia 
20. Before birth, SCs actively proliferate, whereas gonocytes proliferate only until 
around 14.5–16.5 dpc in mice and then enter mitotic arrest 21,22. In mice, the 
prevention of meiosis at this time point is achieved by the degradation of retinoic 
acid (RA) by CYP26B1 expressed by somatic cells in the testis, as well as by the 
expression of pluripotency-associated genes in the gonocytes 23–25. 
 
Figure 1.  Overview of the process of male sex determination in mice. When the primordial germ 
cells (PGCs) arrive at the bipotential gonad at 10.5 dpc, at the same time, Sry is induced 
and the supporting cells reorganize and encapsulate the PGCs. By 11.5 dpc, the 
supporting cells start expressing Sox9, which suppresses the ovarian pathway and 
initiates the male sex determination pathway. Upregulation of Sox9 activates several 
male-specific genes for testicular development, including Amh, which regresses the 
Müllerian ducts. At 12.5 dpc, the testis cords form and the male morphological 
characteristics become evident. By 13.5 dpc, the testis cords become fully developed. 
Sheyla Cisneros Montalvo 
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At 18.5 dpc, gonocytes begin to migrate to the basement membrane 26. Generally, 
the molecular control of gonocyte migration has not yet been well characterized; 
however, it has been suggested that FGF signaling is the key regulator of gonocyte 
migration. Upon FGF signaling, the glial cell line-derived neurotrophic factor 
(GDNF) pathway is triggered, which in turn activates the mitogen-activated protein 
kinases (MAPK) and phosphatidylinositol 3-kinase (PI3K)/protein Kinase B (Akt) 
signaling pathways in these cells during gonocyte migration 27. In addition, it has 
been reported that the stem cell factor (also known as KIT ligand) and platelet-
derived growth factor (PDGF) secreted by SCs promote gonocyte migration 28–31. 
After migration, the gonocytes become spermatogonia and can be identified through 
the expression of GFRA1 and cytoplasmic FOXO1 27. 
2.1.2 Postnatal testicular development 
At birth, the testis cords develop into seminiferous tubules. In addition, germ cells 
reassume the cell cycle and SCs start actively proliferating (Figure 2). Gonocytes, 
now called spermatogonia, reassume the cell cycle at 1 dpp (days post partum) in 
mice 26, regulated by PDGF signaling 29,32. Notably, some spermatogonia form the 
SSC pool 33, and another subset differentiate to participate in the first round of 
spermatogenesis. The first round of differentiation of spermatogonia usually takes 
place at 17 dpp when RA, synthesized by SCs, stimulates a subset of spermatogonia 
to express Stra8 (stimulated by RA gene 8) and cKit (cellular homolog of feline 
sarcoma viral oncogene v-kit) and induce their differentiation 34. Then, SCs stay at 
the basement membrane and continue actively proliferating until 17 dpp in mice 22. 
After the gradual reduction in proliferation, the SCs differentiate into mature cells 
and form the blood–testis barrier (BTB). Each mature SC nurses a limited number 
of germ cells in the adult testis 35; hence, the number of SCs reflects the size of the 
testis and the efficiency of sperm production. 
Review of the Literature 
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Figure 2.  Postnatal testicular development in mice. Before birth, the gonocytes are maintained in 
a quiescent state because of the degradation of retinoic acid (RA) by CYP26, expressed 
in somatic cells. At this point, the Sertoli cells (SCs) are still actively proliferating. After 
birth, the gonocytes migrate to the basement membrane via the action of KIT and 
platelet-derived growth factor (PDGF) signaling. Once they reach the basement 
membrane, they become spermatogonia and reassume proliferation. By 17 dpp, RA 
induces the expression of Stra8 in spermatogonia and meiosis begins, while SCs stop 
proliferating and form the blood–testis barrier (BTB). At the adult stage, the seminiferous 
tubules consist of germ cells in different steps of differentiation and quiescent SCs that 
nurse spermatogenic cells in every spermatogenic round. 
2.2 Testicular composition 
The testis consists of long coiled seminiferous tubules and an interstitial space 
between them covered by a fibrous envelope called tunica albuginea. These 
seminiferous tubules and the interstitial space host specific cell types essential for 
spermatogenesis. Spermatozoa migrate from the lumen of the seminiferous tubule to 
the rete testis and then move to the efferent ducts and the epididymis for further 
maturation.  
Sheyla Cisneros Montalvo 
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2.2.1 Seminiferous epithelium 
2.2.1.1 Spermatogonial stem cells and niche 
Generally, SSCs are the precursors of all spermatozoa produced during the 
reproductive lifespan of a male. This cell population renews itself to maintain its 
number, and a subset of these cells become progenitor cells to enter the 
spermatogenic cycle (Figure 3). This fate decision is controlled by factors produced 
in a specific environment called the niche. 
The niche of the SSCs is a three-dimensional environment that consists of the 
cells surrounding the SSCs and specific autocrine and paracrine factors. Over the 
years, different factors have been reported to affect the dynamics and function of 
SSCs. Among paracrine factors, GDNF, which is secreted by SCs, PTMs, and 
vascular endothelial cells, has been reported to be the most important factor for SSC 
self-renewal by blocking their differentiation 36–39. Deletion of GDNF receptors 
causes the depletion of SSCs 40. Conversely, its overexpression causes the 
accumulation of undifferentiated spermatogonia 37. Fibroblast growth factor 2 
(FGF2) also regulates SSC maintenance. Extended stimulation of FGF2 in the testis 
results in the accumulation of undifferentiated spermatogonia and represses the 
expression of the CYP26B1 enzyme to control RA 41. Besides, several intrinsic 
factors in SSCs, such as promyelocytic leukemia zinc finger (PLZF) 42,43, TATA-
box binding protein associated factor 4b (TAF4B) 44, spalt-like transcription factor 
4 (SALL4) 45,46, and forkhead box O1 (FOXO1) 47, promote self-renewal and cell 
fate and survival. 
In rodents, SSCs constitute a subset of a heterogeneous population of 
spermatogonia (type A, intermediate, and type B spermatogonia), which reside in 
the basement membrane of the seminiferous epithelium. Notably, the type A 
spermatogonia are further divided into an undifferentiated and a differentiated 
subpopulation. The undifferentiated subpopulation consists of A-single (As), A-
paired (Apr), and A-aligned (Aal) chains of 3 to 32 undifferentiated spermatogonia. 
According to the “A-single” model of spermatogonial differentiation 48, the SSCs are 
all As spermatogonia; however, recent studies have shown that As spermatogonia 
population consist of authentic SSCs, and SSCs in transition to a progenitor 
phenotype 49,50. On the other hand, Apr and Aal spermatogonia are progenitors cells 
connected by intracellular bridges formed after incomplete cytokinesis 51. As a 
consequence of terminal differentiation, undifferentiated spermatogonia form A1 
spermatogonia via RA induction 52. A1 differentiated spermatogonia further divide 
mitotically to form A2 > A3 > A4 > intermediate > B spermatogonia > 
spermatocytes, before undergoing meiotic division. 
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Figure 3.  Formation of the spermatogonial stem cell syncytium in rodents. This process starts 
from the A-single (As) spermatogonia, which divide mitotically to give rise to A-paired 
(Apr) spermatogonia. Mitotic division of Apr spermatogonia produces A-aligned 4 (Aal4) 
spermatogonia and then Aal8 and Aal16 spermatogonia. All these cells constitute the 
undifferentiated spermatogonia. Unlike regular mitosis, cytokinesis in undifferentiated 
spermatogonia is incomplete. Therefore, these cells are connected to other cells via 
cytoplasmic connections. Undifferentiated spermatogonia transition into A1 as a 
commitment to spermatogenesis. They then divide (A1 > A2 > A3 > A4 > intermediate) 
and eventually form B spermatogonia, which then give rise to spermatocytes that 
undergo meiosis to produce haploid spermatids. 
2.2.1.1.1 Spermatogenesis 
Spermatogenesis is a synchronized and continuous process in which differentiation 
from diploid germ cells to haploid spermatozoa occurs. This process takes around 
34 days in mice 1 and 74 days in humans 62 and is divided into three phases: mitotic 
amplification phase, meiotic phase, and postmeiotic phase of spermiogenesis. 
During the mitotic phase, different subsets of undifferentiated spermatogonia 
proliferate or commit to spermatogonial differentiation, as described in the previous 
chapter. In theory, one committed spermatogonium can give rise to 2,048–4,096 
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spermatozoa by the end of the spermatogenic cycle 48; however, several apoptotic 
mechanisms decrease the final output 49. 
Preleptotene spermatocytes duplicate the amount of their DNA (4C) and proceed 
to meiosis. Spermatocytes first go through prophase I, which consists of six phases: 
preleptotene, leptotene, zygotene, pachytene, diplotene, and diakinesis. During these 
phases, the cell body and nucleus increase in size, sister chromatids condensate, the 
synaptonemal complex is formed, crossing over takes place, chiasmata become 
visible, and cells with recombined chromosomes split. This step involves different 
genes, such as Rec8, Smc1b, Sycp3, Spo11, Dmc1 50–54 and Stra8 55, as the earliest 
regulator of meiosis induced by RA signaling 56,57. The first meiotic division is 
accomplished within metaphase I, anaphase I, and telophase I, resulting in cells 
called secondary spermatocytes with a 2C amount of DNA. During the second 
meiotic division, no DNA replication occurs and chromatids are segregated into two 
haploid cells (1C) called rounded spermatids (RSs). 
During spermiogenesis, these RSs undergo morphological and structural 
changes to become spermatozoa. The cellular cytoplasm reduces, histones are 
replaced by protamines, and the formation of acrosomes and flagella takes place. 
Finally, mature spermatids are released to the lumen for further maturation in the 
epididymis 60,61. 
2.2.1.1.2 Stages of the seminiferous epithelial cycle 
The seminiferous epithelium consists of germ cells in different stages of 
differentiation. Classification of the epithelium according to the development of the 
acrosome of the spermatids forms highly defined associations called stages (Figure 
4). The most undifferentiated cells are located next to the basement membrane. As 
the spermatogenic cycle proceeds, the most differentiated germ cells localize toward 
the lumen. In general, mice have 12 stages (I to XII) 62, rats have 14 (I to XIV) 63,64, 
and humans have 6 (I to VI) 65,66 or 12 67, depending on the criteria.  
As these stages take place progressively, each routine histological cross section 
of a seminiferous tubule can display one or two stages of the seminiferous epithelial 
cycle. Each stage displays a specific light absorption pattern (Figure 4), which allows 
the discrimination of specific stages in the seminiferous tubules under a microscope. 
Dissection of defined stages is very useful during toxicological and comparative 
analyses because it allows the evaluation of changes in cellular composition, 
biochemistry, and gene expression at each stage 64,68,69. 
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Figure 4.  Cellular organization of the stages of the seminiferous epithelium in mice. The outer ring 
represents the transillumination properties of each spermatogenic stage. This clock 
contains all the cell types in each stage: Aund, undifferentiated spermatogonia; A1, A2, 
A3, A4, In, and B, differentiated spermatogonia; PI, preleptotene spermatocytes; L, 
leptotene spermatocytes; Z, zygotene spermatocytes; P, pachytene spermatocytes; D, 
diplotene spermatocytes; m2°m, meiotic metaphase; 1–7, rounded spermatids (RSs); 
8–16, elongated spermatids (ESs). The width of each stage represents the duration of 
one spermatogenic cycle 70. 
2.2.1.2 Sertoli cells 
Generally, SCs are the only somatic cells within the seminiferous epithelium that 
create a unique environment for nursing germ cells during spermatogenesis. These 
cells proliferate until two weeks in mice 22 or three weeks in rats 71 postnatally. By 
four weeks in mice and five weeks in rats, they acquire a mature quiescent status 
with cytoplasmic branches, BTB establishment, and the acquisition of the full 
capacity to sustain developing germ cells. 
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2.2.1.2.1 Sertoli cell proliferation 
Proper proliferation of SCs determines the sperm production capacity of the testis as 
each SC can nurse a limited number of germ cells (Figure 5). Follicle-stimulating 
hormone (FSH) is the main regulator of SC proliferation during fetal and neonatal 
life. This hormone exerts its effects by interacting with the FSH receptor (FSHR) on 
the cell surface of the SCs. It has been widely reported that diminished FSH levels 
resulting from applying inhibitors or using transgenic models negatively affect the 
number of SCs 72–74.  
Notably, AMH, a member of the transforming growth factor β (TGFβ) 
superfamily, mentioned in previous chapters, is expressed in SCs during the 
masculinization of the bipotential gonad to induce the regression of the Müllerian 
ducts. After birth, this expression decreases gradually until SCs become mature. 
Thanks to its expression pattern, AMH has been widely used as a distinctive marker 
for determining the status of SCs in rodents and humans 75,76.  
Activin A is another member of the TGFβ superfamily that also regulates the 
proliferation of SCs during human and mouse fetal and postnatal testicular 
development. Activin A, a homodimer consisting of two β inhibin subunits (βA:βA 
homodimers) encoded by the Inhba gene, is produced by Leydig cells, SCs, and 
PTMs. During the fetal period, Leydig cells are considered the main source of activin 
A, whereas in neonatal life, PTMs are suggested to be the main source 77–79. 
Generally, the levels of activin A become elevated during the proliferation of SCs 
and decrease as the animal reaches adulthood 79. Complete deletion or specific 
deletion of Inhba in Leydig cells shows the importance of activin A for SC 
proliferation, as its deletion diminishes the number of SCs and results in a small-
sized adult testis 78,80.  
Interleukin-1 (IL-1) not only plays an important immunologic role but also plays 
a role in the proliferation of SCs. Generally, IL-1 exists as two major agonist 
isotypes, IL-1α, and IL-1β, which are both produced by SCs and Leydig cells in 
humans 81 and by interstitial macrophages in rodents 82–86. 
2.2.1.2.2 Sertoli cell maturation 
The acquisition of the full capacity of SCs to sustain spermatogenesis is mediated by 
different factors (Figure 5). It is widely known that testosterone functions in the 
virilization of the male embryo and progression of spermatogenesis in adults 20,88. 
However, testosterone may also directly induce the maturation of SCs. Moreover, 
the androgen receptor (AR) is expressed in SCs, Leydig cells, and PTMs in the testis 
89. However, the expression in SCs starts postnatally and increases during postnatal 
testicular development, which correlates with the gradual cessation of SC 
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proliferation 90. It has been shown that premature expression of AR in fetal SCs 
induces the maturation of SCs, which causes a reduce number of SCs and small-
sized adult testis. Besides, gene expression analysis of SCs in this transgenic mouse 
model shows elevated mRNA levels of tight junctions and phagocyte-related 
function, demonstrating the premature maturation of SCs 91. The upregulation of 
cyclin-dependent kinase (CDK) inhibitor 1B (p27Kip1) 92, which inhibits CDKs, 
ceases the proliferation of SCs. Inhibition of CDKs prevents the phosphorylation of 
RB, hence preventing the activation of cell cycle progression 93.  
Triiodothyronine (T3) is a thyroid hormone implicated in the maturation of SCs. 
It has been suggested that the binding of T3 to its receptor in SCs induces the 
upregulation of Cx43, a constitutive protein of gap junctions that inhibits the 
proliferation of SCs. Besides, specific deletion of thyroid hormone receptor alpha 1 
(TRα1) in SCs results in the increased proliferation of SCs with higher sperm 
production, whereas exposure of immature SCs to higher doses of T3 decreases their 
proliferation 94–96. 
Another hallmark of SC maturation is the formation of the BTB. This barrier 
consists of tight junctions (formed by claudins 1–24, JAM 1–3, and ZO-1), an 
ectoplasmic specialization (formed by α1β6 integrin, ESPIN), a gap (formed by 
connexin 43), and desmosome-like junctions (formed by desmoglein, desmocollin, 
and vimentin) 97. The BTB divides the seminiferous tubules into two compartments: 
a basal compartment, in which the SSCs and other spermatogonia are found, and an 
adluminal compartment, which consists of spermatocytes and spermatids. This 
complex structure maintains tissue homeostasis by protecting the developing germ 
cells from endo- or exogenous substances and autoimmune responses. 
Mature SCs play a role not only during testicular development and 
spermatogenesis, but also during the last stage of spermiogenesis. In the last step of 
elongation, spermatids are still anchored to the branches of the SCs. When the 
residual body is released from elongated spermatids (ESs), SCs with a class B 
scavenger receptor type I recognize the phosphatidylserine exposed on the cell 
surface of the residual body and phagocytose it. It has been shown that impaired 
phagocytosis by SCs decreases the number of epididymal sperm 98. Moreover, SCs 
are also important for the release of mature sperm to the lumen by modification of 
the apical ectoplasmic specializations 99. 
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Figure 5.  Sertoli cell (SC) differentiation in mice. During testicular development, SCs differentiate 
into fetal, juvenile, and adult SCs. Each phase is characterized by a specific expression 
profile and functional characteristics. Fetal SCs are first identified when precursor cells 
in the bipotential gonad start expressing SOX9 induced by SRY, which then induces 
male sexual differentiation of the testis. At the same time, the secretion of anti-Müllerian 
hormone (AMH) by fetal SCs induces the regression of the Müllerian ducts. At this point, 
the SCs express follicle-stimulating hormone receptor (FSHR) and interleukin-1 (IL-1) 
and actively proliferate. After birth, SCs support spermatogonial stem cell (SSC) niche 
formation and continue proliferating actively. At around 17 dpp, the SCs gradually cease 
to proliferate and start expressing AR and forming the blood–testis barrier (BTB). In the 
adult phase, the SCs differentiate into mature SCs and become mitotically quiescent 
somatic cells that can now support spermatogenesis. 
2.2.1.3 Retinoblastoma and E2F protein families 
2.2.1.3.1 Retinoblastoma protein family 
The RB family consists of pRb, p107, and p130 mammalian proteins. These proteins 
are known to be transcriptional repressors because their major function is to inhibit 
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the expression of cell-cycle-related proteins 162. Notably, pRb, p107, and p130 are 
considered to be closely related because they share a common pocket domain for 
interaction with viral oncoproteins and cellular factors, such as the E2F family. pRb 
is an RB that is ubiquitously expressed in adult tissues and is mutated in different 
types of human cancer, such as retinoblastoma, small-cell lung carcinoma, and 
osteosarcoma 163. p107 has been found to be mutated only in human B-cell 
lymphoma 164, whereas p130 been found to be mutated in nasopharyngeal carcinoma 
243 and lung carcinoma 244. Despite the low-frequency mutation of p107 and p130 in 
human cancer, both of them contribute to some tumor suppressor functions in an Rb 
mutated background 165. Moreover, these three members of the retinoblastoma 
family have some overlapping and opposing roles (for a review, see 166,167). 
2.2.1.3.2 E2F protein family 
The E2F protein family includes eight genes, E2F1–E2F8, which encode nine 
proteins (because E2F3 has two products, E2F3a and E2F3b). According to the 
ability to activate or repress transcription, E2F proteins are divided into activators 
(E2F1, E2F2, and E2F3a), which are expressed during the G1/S-phase, and 
repressors (E2F3b, E2F4–E2F8), which are expressed during the G0/G1-phase of the 
cell cycle (for a review, see 172). All these E2F transcription factors are known to 
regulate the cell cycle progression and apoptosis 173,174. Generally, E2F1–E2F5 
activate or repress transcription by interacting with the RB protein family (pRb, 
p130, and p107). As E2F6–E2F8 lack sequences for binding to the Rb protein family, 
they perform their repression function by other mechanisms 175,176. 
Despite the common domain that the RB protein family shares among its 
members, they interact differently with the E2F proteins. pRb interacts with E2F1 
177, E2F2 178, E2F3 179, and E2F4 180, whereas p130 and p107 interact with E2F4 181 
and E2F5 166,175,180. These associations occur at different phases of the cell cycle. 
While pRb interacts with the E2F proteins in nondividing and dividing cells, p107 
interacts primarily in nondividing cells and p130 interacts especially during the S-
phase of the cell cycle 175. 
Rb family members and cell cycle 
Inhibition of cell cycle progression is achieved by blocking the transcriptional activity 
of E2F proteins. In quiescent cells, unphosphorylated RB forms complexes with E2F 
proteins to inhibit the activation of specific genes for cell cycle progression. When the 
cell becomes committed to divide, at the early G1-phase, cyclin/CDK complexes 
phosphorylate Rb. This disrupts the Rb/E2F association, causing the release of E2F, 
which then activates or represses target genes (Figure 6) 171.  
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Figure 6.  Retinoblastoma (RB) and E2F family proteins in the cell cycle. RB and pRb represent 
the unphosphorylated RB protein family member and the retinoblastoma protein, 
respectively, and  represents the phosphorylated forms. In the G0- and early G1-
phases, RB physically associates with E2F factors and blocks their transactivation 
domain. In the late G1-phase, phosphorylated RB releases E2F, allowing the expression 
of genes that encode products necessary for S-phase progression. 
2.2.1.3.3 RB/E2F pathway in the testis 
In the mouse testis, RB protein family and E2F transcription factors are expressed in 
different cell types and a stage-specific pattern. pRb is expressed in SC, dividing 
spermatogonia, and preleptotene spermatocytes, whereas p107 is expressed in 
meiotic spermatocytes and p130 is expressed in SCs 8,182. Regarding E2F proteins, 
E2F1 is expressed in the leptotene to early pachytene spermatocytes of stages IX to 
XI in mice, as well as in the spermatogonia. E2F2 is expressed in the spermatocytes 
of the mid to late prophase of meiosis, E2F3 in SCs and differentiated 
spermatogonia, E2F4 in SCs, and E2F5 in B spermatogonia, preleptotene 
spermatocytes, and pachytene spermatocytes 8,183. 
Using transgenic animals, different roles of the RB and E2F protein family have 
been indicated during spermatogenesis. Rb regulates the entry of gonocytes into cell 
cycle arrest in the fetal testis at 14.5 dpc. In Rb-null mice, the gonocytes do not enter 
cell cycle arrest and continue proliferating. Later on, the gonocytes achieve cell cycle 
arrest because of the compensatory effects of Cdkn1b and Cdkn2b 184. In the germ 
cells, Rb insufficiency results in an impaired self-renewal capacity of SSCs (As) and 
the accumulation of progenitor spermatogonia (Aal). Consequently, the mice become 
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sterile as a result of the rapid exhaustion of the SSC pool 185. On the contrary, Rb 
insufficiency in SCs induces cell cycle reentry of adult quiescent SCs. However, as 
SCs do not display a mature status, spermatogenesis fails 8,186.  
Recently, we have reported that pRb and the E2F3 transcription factor are 
coexpressed in mouse SCs and that they mediate SC maturation and cell cycle 
quiescence 8. E2F1 has been linked to the induction and inhibition of apoptosis in 
the testis. Ablation of E2F1 in different genetic backgrounds has been shown to 
cause the disruption of spermatogenesis 187,188. A later study showed that E2F1 
promotes the apoptosis of spermatogonia during the first wave of spermatogenesis 
and inhibits the apoptosis of meiotic germ cells 188. Besides, E2F1 may also regulate 
the function of SCs and induce their apoptosis in the absence of Rb 186.  
Notably, the testis phenotype of E2f2-null mice has not yet been studied. However, 
studies on the immunological functions of E2F2 have described that E2f2-null mice 
are viable and fertile and produce normal offspring, which may suggest that E2F2 is 
not essential for spermatogenesis 245. E2F3 protein expression has been reported in 
Sertoli and spermatogonia cells 183. However, to our knowledge, this is the first study 
investigating the protein expression of E2F3 isoforms and their function in the SC of 
the mice testis. E2f4-null mice die at birth as a result of respiratory system infections, 
challenging the study of E2F4 in spermatogenesis 189. Treating the mother with 
antibiotics can generate E2f4-null littermates that survive until adulthood. These E2f4-
null mice are infertile. Surprisingly, no phenotype was seen in the adult testis, but in 
the epididymis, which may suggest that E2F4 is dispensable for spermatogenesis but 
essential for epididymal function 189. This result is in line with the notion that E2F4 
and E2F5 may have overlapping functions, which may be the reason for a normal testis 
phenotype 190. Besides, mice with double deletion of E2F4 and E2F5 are not viable 
and die in utero 180. Generally, E2F6 is dispensable in cell cycle progression or 
inhibition in the testis; however, it has been reported that E2F6 represses the expression 
of meiosis-specific genes in somatic cells 191. 
As mentioned above, some RB and E2F proteins compensate for the absence of other 
proteins in terms of function. However, more studies need to be performed to determine 
the compensatory and specific roles of each protein or complex (RB/E2F) in the testis. 
2.2.1.4 Upstream stimulatory factor 1 
Upstream stimulatory factor 1 is a general ubiquitously expressed transcription 
factor that plays many roles in biological systems, such as glucose and lipid 
metabolism 148,149. However, the expression of USF1 and its ability to regulate 
spermatogenesis is still poorly characterized.  
Generally, USF1 belongs to the basic helix-loop-helix family of transcription 
factors. Moreover, USF proteins are encoded by Usf1 and Usf2 genes. To regulate 
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transcription, the USF1 homodimer or USF1/USF2 heterodimer binds specific DNA 
sequence motifs known as E-boxes (CACGTG or CANNTG) in the target genes 
145,146. The first role identified for USF1 is the potential activation of the adenovirus 
major promoter in HeLa cells 147. Later on, USF1 has been linked to lipid and glucose 
metabolism as it targets specific genes, such as L-type pyruvate kinase, fatty acid 
synthase, and glucokinase 148,149. Besides, several genome-wide linkage scan studies 
have strongly linked Usf1 to familial combined hyperlipidemia 5,150, coronary 
atherosclerosis 151,152, and acute cardiovascular events 153,154. Moreover, different 
clinical studies have associated gene variants of Usf1 to type 2 diabetes, metabolic 
syndrome, and obesity 155–157. 
It has been reported that Usf1-deficient mice in different hybrid backgrounds are 
phenotypically normal, healthy, and fertile 159,246,246. This normal phenotype has been 
suggested to be due to the compensatory effects of USF2 because its level is elevated in 
Usf1-deficient mice 159. Laurila et al., 6 reported that Usf1-deficient mice fed with an HFD 
display a beneficial metabolic phenotype in comparison to control mice on HFD. They 
also display lower-body fat weight gain than that of the control animals on HFD and 
exhibit increased brown adipose tissue activity, elevated high-density lipoprotein 
cholesterol, decreased triglyceride level in plasma, and improved insulin sensitivity, 
suggesting that the inactivation of USF1 protects mice against diet-induced dyslipidemia, 
obesity, insulin resistance, and hepatic steatosis. Therefore, it has been proposed that 
USF1 can be used as a potential drug target for cardiometabolic diseases 6. 
In the testis, USF1 has been identified as a potential regulator of SC 
differentiation, as Usf1 mRNA and USF1 protein are upregulated in SCs at around 
11 dpp in rats, corresponding to the maturation of SCs in rats 146. Several in vitro 
studies have indicated that the DNA-binding activity of USF1 to Fshr, Gata4, Nr5a1 
(also known as SF-1), and Shbg (also known as androgen-binding protein) promoters 
increases in the SCs of rats at 11 dpp 146,160.Besides, in another study, it has been 
indicated that USF1 may also regulate Fshr transcription specifically in 
differentiating SCs as it actively binds the promoter of Fshr in differentiating SCs in 
mice and rats. Despite the strong binding capacity, the testes of Usf1-deficient mice 
at 21 dpp of age did not display any differences in the Fshr mRNA levels in 
comparison to wild-type (WT) mice 161,247, which could be the result of a 
compensatory function by Usf2. 
2.2.2 Interstitial space 
2.2.2.1 Testicular vasculature 
In general, the testicular vasculature (i.e., blood and lymphatic vasculature) is formed 
during fetal testicular development simultaneously with the expression of SRY and 
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the formation of the testis cords 100,101. Abnormal development of the testicular 
vasculature leads to intratesticular hypoxia and germ cell apoptosis 102. 
In the adult, the testis is irrigated by three vessels (Figure 7), testicular, 
cremasteric, and deferential arteries, among which the testicular artery is the 
principal source. This testicular artery, which originates from the abdominal aorta, 
courses along the surface of the testis and then traverses the tunica albuginea and 
branches into a complex network of capillaries that travel among the seminiferous 
tubules 103. The veins emerging from the testis form a conglomerate called the 
pampiniform plexus, which transports the drained blood from the testis, epididymis, 
and vas deferens and also regulates the temperature of the testis. 
This complex vasculature provides a path for delivering pituitary hormones, 
micronutrients, and oxygen to the interstitial space among the seminiferous tubules. 
It also transports intratesticular testosterone (ITT) and helps get rid of it from the 
testis. The transfer of particles from plasma to the interstitial space depends on the 
vascular permeability and blood flow. Blood flow is positively correlated with the 
serum testosterone level and testis volume 104. Testosterone, via AR in the smooth 
muscle cells of the vasculature, mediates testicular vasomotion 105,106, which is 
important for proper interstitial fluid homeostasis in the testis. 
 
Figure 7.  Testicular vasculature. The testis is irrigated by three arteries—the testicular, 
deferential, and cremasteric arteries—which deliver micronutrients, hormones, and 
oxygen to the testis. The testicular veins then collect waste and direct the testosterone 
out of the testis. 
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2.2.2.1.1 Endothelial cells 
Endothelial cells line blood and lymphatic vessels and are known to regulate 
permeability, passive diffusion, active transport of molecules, and control of 
vasodilatation of the vasculature. In terms of morphology, endothelial cells are 
classified as continuous, discontinuous, or fenestrated endothelia, with each type 
differing in the organization of the endothelial cells and permeability. The testis 
consists mostly of fenestrated endothelia, which are characterized by the presence 
of transcellular pores with a diameter of around 60–80 nm 107, which allow the 
transport of macromolecules and migration of cells. These pores consist of a 
diaphragm that acts as a filter. So far, the only protein described forming the 
diaphragm is PLVAP 9. 
In the adult testicular vasculature, similar to SCs and PTMs, endothelial cells 
produce GDNF under androgen stimulation, which regulates SSC homeostasis 1–4. 
2.2.2.2 Plasmalemma vesicle-associated protein 
Generally, PLVAP is a glycosylated type II transmembrane protein expressed in the 
diaphragm of fenestrated endothelia (i.e., fenestrae, caveolae, and transendothelial 
channel subcellular organelles), which line the inner surface of the microvasculature 
192. The expression of PLVAP is specifically localized to the diaphragm and is crucial 
for its formation. Moreover, this protein is not expressed in the endothelial cells of 
large vessels except in the endocardial lining of the heart chambers 193. As it has been 
shown that this protein is expressed only in endothelial cells, it has been widely used 
as a blood endothelium specific marker. 
Notably, PLVAP is important for the integrity of blood vessels and barrier 
function. Several in vivo and in vitro studies have demonstrated that PLVAP is 
responsible for the formation of diaphragms in caveolar and fenestral subcellular 
organelles 9,192. It has also been observed that Plvap-null mice with a C57BL/6N 
genetic background die before birth because of subcutaneous edema, hemorrhages, 
and defects in the vascular wall of subcutaneous capillaries 194. In a mixed 
background, Plvap-deficient mice can survive for a few weeks after birth 9,194, but 
they die soon because of severe enteropathy and edema of the intestine, kidneys, and 
pancreas. Lack of PLVAP in the endothelium impairs the barrier function, causing a 
massive leakage of molecules and plasma proteins 9. 
It has also been shown that PLVAP regulates the traffic of immunological cells. 
Several in vitro and in vivo studies have shown that PLVAP mediates the traffic of 
lymphocytes into the lymph nodes 195. In addition, PLVAP regulates the seeding of 
fetal liver-derived macrophages to different tissues 10.  
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In cancer, PLVAP was first detected in malignant glioma microvasculature 196. 
Then, it was shown that PLVAP is upregulated in different kinds of cancer, such as 
lung, colon, liver, pancreas, ovarian, brain, and breast cancer 196-198. Moreover, 
PLVAP is upregulated in primary and metastatic types of cancer, colocalizing with 
the CD31 antigen, a widely used marker for vascular endothelia 199. It has also been 
shown that PLVAP promotes angiogenesis and growth of cancer cells. Several in 
vitro studies have shown that targeting PLVAP yielded positive results in terms of 
decreasing the size of tumors 200,201, allowing it to be considered a novel drug target 
for the treatment of cancer 196,202. 
Apart from cancer, PLVAP has been identified in other diseases, such as acute 
ischemic brain disease, in which the blood–brain barrier is damaged, increasing the 
permeability of the microvasculature and, hence, leading to brain ischemia, hypoxia, 
and eventually mortality. Moreover, it has also been found that PLVAP is 
upregulated in part of the endothelial cells close to the ischemic area and, hence, is 
suggested to cause hypoxia 202. After traumatic spinal cord injuries, expression of 
PLVAP is observed in newly formed blood vessels. Upregulation of PLVAP is 
thought to induce inflammation and deterioration of neurovascular function in this 
area 203.  
The testicular vasculature consists mostly of fenestrated endothelia. Although 
PLVAP mRNA has been detected in the testis 204, its protein expression is still 
unclear. Immunohistochemical staining of the testes of newborn rats revealed the 
presence of PLVAP in the interstitial space between the seminiferous tubules. 
However, the same study that reported this finding also claims that, in the adult rat 
testis, PLVAP is not expressed in the interstitium but in the germ cells 204. 
Nevertheless, the functional role of PLVAP in the testis remains unknown. 
2.2.2.3 Leydig cells 
Leydig cells are the steroidogenic cells of the testis that regulate the production of 
testosterone for the formation of the male genitalia and the production of sperm in 
the adult stage. Two populations of Leydig cells have been identified in mammals: 
FLCs and adult Leydig cells (ALCs) 109. Although their developmental origin is 
still a matter of controversy, it is understood that each population derives from 
different progenitor populations in fetal life. Generally, FLCs are first identified at 
12.5–13.5 dpc in rodents and increase in number during fetal life 110,111. At birth, 
the mouse FLC population starts gradually atrophying, and at around 11 dpp, ALCs 
start populating the testis 112. By 56 dpp, the percentage of FLC drops to around 
20% only of the total Leydig cells 113. During fetal life, FLCs cannot synthesize 
testosterone because they do not express 17β-hydroxysteroid dehydrogenase type 
3 (17β-HSD3); they only secrete androstenedione, which is converted into 
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testosterone by fetal SCs that express 17β-HSD3 113,114. Notably, the function of 
the remaining FLCs in the adult testis is still unclear. However, ALCs express 17β-
HSD3 and can synthesize testosterone following luteinizing hormone (LH) 
stimulation. 
2.2.2.4 Peritubular myoid cells 
Generally, PTMs are thin smooth-muscle-like cells that surround the seminiferous 
tubules. Although these cells can be identified in the testis at 13.5 dpc in mice 125, 
their origin remains unclear. These cells regulate postnatal testicular growth 126 and 
provide physical support and contraction of tubules in the adult testis for the release 
of mature spermatozoa to the epididymis 127. Besides, PTMs are regarded as 
structural cells because they secrete components of the intercellular matrix, such as 
collagens (I, VI, and XVIII), laminin, and fibronectin 128. According to an in vitro 
study, GDNF secretion induced by testosterone in PTMs regulates the maintenance 
of SSCs 129. 
2.2.2.5 Macrophages 
Macrophages are the most abundant cell population of the immune system in the 
adult testis 115–117 with various functions in different organs, such as an immunologic 
function, a tissue homeostatic function, and a regenerative and developmental 
function 118–120. In the adult testis, two populations of testicular tissue-resident 
macrophages have been identified in terms of tissue localization, morphology, and 
gene profile. The macrophages situated in contact with Leydig cells, which display 
an immunosuppressive profile, have been suggested to play a role during postnatal 
Leydig cell development, regeneration, and steroidogenesis 120,121, whereas the 
macrophages situated in close contact with PTMs, which highly express genes for 
antigen processing and presentation, have been suggested to regulate the 
differentiation of SSCs 122. 
It has been reported that testicular tissue-resident macrophages have a dual 
origin: the yolk sac (during the embryonic period) and the bone marrow (postnatally) 
122. It has also been suggested that macrophages localized close to Leydig cells have 
an embryonic origin 123, whereas those close to PTMs may have originated 
postnatally from the bone marrow 124. 
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2.3 Endocrine regulation of testicular function 
In normal testicular development, male hormone secretion, and spermatogenesis are 
regulated by the hypothalamic-pituitary-gonadal axis (Figure 8). The hypothalamus 
secretes gonadotropin-releasing hormone, which induces the secretion of LH and 
FSH from the gonadotrophic cells in the anterior pituitary. Then, LH and FSH 
stimulate the testis, which in turn secretes testosterone by Leydig cells and inhibin B 
by SCs 131. This mechanism sustains closed-loop feedback that maintains a balance 
of serum levels of reproductive hormones.  
Previously, it has been believed that spermatogenesis is maintained by a high 
concentration of ITT, 50 to 100 times higher than in serum. However, in the last 10 
years, transgenic mice models and clinical cases have provided new information 
regarding the hormonal need for spermatogenesis. In 2001, Zhang et al. 135 described 
the testicular phenotype of a mouse model lacking the LH receptor (LuRKO). 
Notably, LuRKO mice showed a small-sized testis and at six weeks of age displayed 
spermatogenic arrest around the spermatid stage. Hormone measurements revealed 
that the FSH level was twofold higher in serum and that the ITT levels were 
significantly reduced in LuRKO compared to WT mice, explaining the 
spermatogenic defect. However, at 12 weeks of age, the LuRKO mice displayed 
complete spermatogenesis, raising the question of whether the significantly low 
quantities of testosterone or the twofold higher FSH levels in the LuRKO mice were 
the underlying factors maintaining spermatogenesis. Moreover, antiandrogen 
treatment with flutamide blocked the progression of spermatogenesis in the testes of 
LuRKO mice and revealed that low ITT levels can drive spermatogenesis.  
Different transgenic animals studying the function of FSH in spermatogenesis 
have supported the function of FSH on the proliferation of SCs and therefore the 
testis size 73,130. Mice deficient in FSH-specific β subunit (FSHβKO) 240 and FSHR 
(FSHRKO)133,239 display small-sized but fertile testes with normal spermatogenesis. 
Therefore, FSH is not essential for spermatogenesis.  
In 2018, Odewule et al. 134 crossed a mouse line with an active mutation of FSHR 
in SCs, with an absent testis phenotype, together with LuRKO mice. Animals with 
strong FHSR stimulation and without testosterone were found to display normal 
spermatogenesis. Double knockout mice were treated with antiandrogen flutamide 
to eliminate possible testosterone action; however, no effect on spermatogenesis was 
observed, suggesting that the overactivation of FSHR can compensate for the AR 
action. Despite the different mechanism of action of FSHR and AR, both can activate 
the MAPK and CREB signaling pathway as a nonclassical testosterone pathway 248, 
which may explain how a strong FSH action can compensate for the absence of ITT 
for normal spermatogenesis. 
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Figure 8. Schematic representation of the hypothalamic-pituitary-testicular axis. GnRH, 
gonadotropin-releasing hormone; LH, luteinizing hormone; FSH, follicle-stimulating 
hormone. 
2.4 Morphometric methods to study testicular cell 
dynamics 
The testis is a complex organ that consists of a heterogeneous population of germ 
cells and somatic cells. The proportion of each testicular population fluctuates during 
the fetal, juvenile, and adult stages. Besides, the cellular shape, size, and organization 
of the seminiferous tubules vary according to the stage of spermatogenesis, thus 
making the study of the testis challenging. Traditionally, standard hematoxylin and 
eosin or periodic acid–Schiff staining is performed on cryopreserved or paraffin 
sections for simple histological assessments. Then, photos are taken using 
conventional microscopes or, currently, automated scanners; however, the 
quantification of specific cell types is performed manually most of the time. 
Detection of specific cell types using immunohistochemistry or immunofluorescence 
techniques helps in the identification and quantification of cells of interest; however, 
this process can take days or even weeks. 
2.4.1 Flow cytometry for the study of testicular dynamics 
Flow cytometry is a laser-based technology that was first introduced in the 1950s to 
detect and measure the number and physical characteristics of cells in suspensions. 
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Currently, modern flow cytometers coupled to immunofluorescence and cell-sorting 
equipment allow researchers to perform multiparameter analysis for single cells to 
investigate parameters such as cell cycle, apoptosis, and even molecular pathways. 
When a single-cell suspension is injected into a flow cytometer, the cells become 
aligned thanks to the hydrodynamic focusing properties created by the outer sheath 
fluid in the flow cytometer (Figure 9). This single line of cells passes through a 
nozzle to a laser beam one cell at a time. As the cells pass through the laser beam, 
forward- and side-scattered light are collected using detectors, and the fluorescent 
light emitted from stained cells is also collected. The direction of the forward- and 
side-scattered light correlates with the size and granularity of the cells, respectively 
(Figure 8). 
In the field of reproduction, flow cytometry coupled to DNA staining is 
performed to identify the status of spermatogenesis in rodents and primates 137–140 as 
well as in the human testis 141. Incorporating DNA stains, such as propidium iodide, 
Hoechst stain, or fxCycle, allows the identification of testicular populations 
according to the amount of DNA. If the testis belongs to a juvenile rodent, two main 
populations can be identified: (1) a 2C population with double the amount of DNA, 
consisting of spermatogonia in the G0/G1-phase of the cell cycle and nonproliferative 
somatic cells, and (2) a 4C population with quadruple the amount of DNA, consisting 
of spermatogonia and somatic cells in the G2/M-phase of the cell cycle and meiotic 
spermatocytes. Unlike in juvenile rodents, the testis of adult rodents consists of 2C, 
4C, and 1C populations. Several defined stages of the epithelial cycle of mice and 
rats have been characterized using flow cytometry coupled to DNA staining, 
enabling the study of the dynamics among the different stages and their further use 
in toxicological studies 138,139. 
Despite the accurate quantitative information that DNA staining provides, the 
2C, 4C, and 1C populations are very heterogeneous populations consisting of germ 
and somatic cells. To resolve this inconvenience, fluorescent antibodies have been 
coupled to flow cytometry. Fluorescent cell-surface antibodies are applied to fresh 
cell suspensions 39,124,142 and intracellular antibodies are applied after the single-cell 
suspension is fixed and permeabilized 142. However, the availability of different cell-
surface markers for testicular cells and the optimization of intracellular antibodies 
are the main challenges in this technique. Additionally, normalization of large-scale 
data has not yet been well established 143,144. 
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Figure 9.  Basics of flow cytometry. (A) When a single-cell suspension is injected into the flow 
cytometer, it is transported to the sheath. The outer sheath applies pressure to the cells 
and, through hydrodynamic focusing, forces the cells to move as a single-file stream of 
cells to the laser beam region. (B) When the laser illuminates the cell, light scatters 
depending on the physical properties of the cell. Notably, forward- and side-scattered 
light correlate with the cell size and granularity of the cells, respectively. 
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3 Aims 
The main objective of this study is to reveal the function of the transcription factor 
USF1, the transcription factor E2F3 alone or in combination with pRb, and PLVAP 
in the development and function of the testis. To facilitate the quantitative analysis 
of the testicular composition, a flow-cytometry-based method was developed. 
 
The specific objectives of this study are as follows: 
 
I. To develop a flow-cytometry-based method to quantitatively analyze the 
testicular cell composition and dynamics of rodents.  
II. To uncover the role of USF1 in the development and function of the testis 
using a USF1 KO mouse model. 
III. To study the function of E2F3 and its interaction with pRb in the 
maintenance of adult SC function by developing SC-specific mouse 
models. 
IV. To study the role of PLVAP during testicular development and function 
using a PLVAP KO mouse model. 
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4 Materials and Methods 
Complete information on the catalog codes of the reagents used is provided in the 
original publications (I–III) and the manuscript (IV). 
4.1 Experimental animals and treatments (I–IV) 
Sprague Dawley rats were obtained from the animal facility of the University of 
Turku and used in Study I, whereas transgenic mouse lines were used in Studies II, 
III, and IV. Briefly, a Usf1−/− mouse line was produced from embryonic stem cells 
deficient in Usf1 from the German Gene Trap Consortium (clone M121B03). (II) 
Amh-cre(Plekha5Tg(AMH-cre)1Flor) 205, Rb-floxed (FVB;129-Rb1tm2Brn/Nci) 206, and E2f3-
floxed (E2f3tm1.1Gle; generously provided by Professor Gustavo Leone, Ohio State 
University) 207 were crossbred to obtain Amh-cre+E2f3flox/flox (SC-E2f3KO) and Amh-
cre+Rbflox/floxE2f3flox/flox (SC-RbKOE2f3KO) selectively in SCs. (III) Young and adult 
Plvaptm1Salm (Plvap−/−) male mice were obtained from Adjunct Professor Pia 
Rantakari, Turku Bioscience Centre, University of Turku, and Åbo Akademi 
University. 
All animals were housed under environmentally controlled conditions (12 h 
light/12 h dark, temperature: 21 ± 1℃). Animals in Studies I, III, and IV were fed 
with SDS R3 (Special Diet Services, E, Spy-free, Whitman, Essex, UK) ad libitum 
and housed in the animal facilities of the University of Turku. On the other hand, 
animals in Study II were fed with Teklad 2916 (Envigo; Indianapolis, IN, USA) ad 
libitum and housed at the Laboratory Animal Center of the University of Helsinki. 
All procedures performed in this study followed the institutional and ethical 
policies of the University of Turku (Studies I, III, and IV) and the University of 
Helsinki (Study II) and were approved by the local ethics committees for animal 
experimentation. 
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4.2 Isolation of stage-specific segments of 
seminiferous tubules (II) 
Seminiferous tubule segments of stages II–V, VII-VIII, and IX–XI were dissected 
from adult mouse testes using a transillumination-assisted microdissection method 
64,68. All seminiferous segments were snap-frozen in liquid nitrogen and stored at 
−80℃ for further gene analysis. 
4.3 Gene expression analysis (II–IV) 
4.3.1 PCR (II–IV) 
Genotyping of the mouse lines was performed from ear (III–IV) or tail (II) pieces. 
DNA was isolated and PCR was performed as described previously 6,8,195,205–207. The 
primers for Usf1 genotyping in Study II were primer A (5′-
GGCGCAGTGGTACTGGAGAGGA-3′), primer B (5′-
ACCCCAAACCCAGGCGGCA-3′), and primer C (5′-
TGACGCGCCGCTGTAAAGTGTTA-3′), which amplify 457 and 167 bp 
fragments for the KO and WT allele, respectively. To confirm the Cre expression for 
Amh-Cre in Study III, primer Cre26 (5′-CCTGGAAAATGCTTCTGTCCG-3′) and 
primer Cre36 (5′-CAGGGTGTTATAAGCAATCCC-3′) were used, which amplify 
a 400 bp fragment. For the Rb flox allele, primer RbP1 (5′-
GGCGTGTGCCCATCAATG-3′) and primer RbP2 (5′- 
AACTCAAGGGAGACCTG-3′) were used, which amplify 700 and 650 bp 
fragments for the Rb-floxed and Rb-WT allele, respectively. For the E2f3 flox allele, 
primer A (5′-GTGGCTGGAAGGGTGCCAAG-3′), primer B (5′-
TGAATCATGGACAGAGCCAGG-3′), and primer C (5′-
GATTGATTCTGGGTTGTCAGG-3′) were used, which amplify 250 and 200 bp 
fragments for the E2f3-floxed and E2f3-WT allele, respectively. In Study IV, primer 
A (5′-GTACATGCAACACCACTGAGC-3′), primer B (5′- 
CCTTGACAGGTGATGTCTGC-3′), and primer C (5′- 
AGTGTATGCTACCACATCTGGCTC-3′) were used, which amplify 1,100 and 
210 bp fragments for the KO and WT allele, respectively. 
4.3.2 Quantitative reverse transcription PCR (II) 
Total RNA from the whole testis was isolated using a NucleoSpin RNA extraction 
kit (Macherey-Nagel, Duren, Germany), and RNA from stage-specific seminiferous 
tubules was isolated using TRIzol (Thermo Fisher Scientific, Waltham, MA, USA), 
Sheyla Cisneros Montalvo 
 40
according to the manufacturer’s instructions 8. cDNA synthesis and quantitative 
reverse transcription PCR (RT-qPCR) were performed using the SsoAdvanced 
Universal SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA) 
following the manufacturer’s instructions. Primers were selected from our previous 
studies 8 or designed using Primer3-based software. Gene expression was normalized 
to housekeeping genes (α-tubulin and Wilms tumor 1 [WT1]) using the Bio-Rad 
CFX Manager software version 3.1 (Table 1). 
Table 1.  Primers used for quantitative reverse transcription PCR (RT-qPCR). 
Gene Amplicon size (bp) Forward primer (5´-3´) Reverse primer (5´-3´) 
Actb 216 AGACTTCGAGCAGGAGATGG AGGTCTTTACGGATGTCAACG 
Amh 149 GCTAGGGGAGACTGGAGAAC CTGGTCCAGGGTATAGCACT 
Ar 169 TACGGAGCTCTCACTTGTGG CCAGAGTCATCCCTGCTTCA 
Bmp4 182 AGGAGGAGGAGGAAGAGCAG CACCTCATTCTCTGGGATGC 
Ck18 167 TGACACCAACATCACAAGGC TGAGGTCCTGAGATTTGGGG 
Csf1 160 CTGCAGCAGTTGATCGACAG GGGTGTTGTCTTTAAAGCGC 
Cxcl12 126 TGCATCAGTGACGGTAAACC CTGAAGGGCACAGTTTGGAG 
Fgf2 104 GCGACCCACACGTCAAACTA CCGTCCATCTTCCTTCATAGC 
Fshr 189 CAGGTCAACATACCGCTTGA TCCCCAGGCTGAGTCATATC 
Gata1 124 TTGTGAGGCCAGAGAGTGTG CCGGTTCTGACCATTCATCT 
Gata4 175 AAAACGGAAGCCCAAGAACC ATAGTGAGATGACAGCCCGG 
Gdnf 151 GACTTGGGTTTGGGCTATGA AACATGCCTGGCCTACTTTG 
Gfra1 152 AGACTTCGAGCAGGAGATGG AGGTCTTTACGGATGTCAACG 
Kitl/Scf 122 CGGGAATCCTGTGACTGATAA GCCAACACCTGACTAGGAAA 
Lhcgr 195 GCAGCTAATCTCGCTGGAGT CTGGAGGGCAGAGTTTTCAG 
Nrg1 172 AGGAACTCAGCCACAAACAAC TCTTGAGGGGTTTGACAGGT 
Pdpn 126 AATCTACTGGCAAGGCACCT CAGTGGTTGTACTCTCGTGT 
Sox9 141 GACTCCCCACATTCCTCCTC CCCCTCTCGCTTCAGATCAA 
Stra8 135 CTCCTCCTCCACTCTGTTGC GCGGCAGAGACAATAGGAAG 
Tuba1 171 ATTGGGGGAGGAGATGACTC ATCCTCCTTGCCTGTGATGA 
Usf1 150 GGAGGGCTCAACATAACGAA AATCTCTGGCTTTGGACAGG 
Usf2 152 GGAGGCGCGATTTGCTTATT TTGTCCTCTGTGTGCCTGTC 
Wnt4 144 ACTGGACTCCCTCCCTGTCT TCACAGCCACACTTCTCCAG 
Wnt5a 138 ATGCAGTACATTGGAGAAGGTG CGTCTCTCGGCTGCCTATTT 
Wnt6 152 GTGGACTTCGGGGATGAGAA CCATGGCACTTACACTCGGT 
Wt1 196 AGTTCCCAACCATTCCTTC CATTCAAGCTGGGAGGTCAT 
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4.3.3 Targeted RNA sequencing (III) 
Total RNA was isolated from snap-frozen adult mouse testes using the RNeasy Mini 
Kit (Qiagen, Hilden, Germany). Total RNA was treated with RNase-free DNase and 
purified using the RNAeasy MinElute Cleanup Kit (Qiagen, Hilden, Germany). A 
panel of target genes was selected for TruSeq Targeted RNA sequencing (Illumina, 
San Diego, CA, USA). These target genes consisted of testicular markers and cell-
cycle-related and specific target genes expressed in juvenile and adult SCs (Table 2). 
Table 2.  Target genes. 
Name Gene ID Name Gene ID Name  Gene ID 
Housekeeping 
Rpl19 19921 Hprt 15452 Ppia 268373 
Paracrine control 
Inha 16322 Inhba 16323 Inhbb 16324 
Sertoli cell 
Cldn3 2739 Rhox5 18617 Gata1 14460 
Cldn11 18417 TRalpha1 21833 Sox9 20682 
Wt1 22431 Espin 75526 AMH 11705 
Ar 11835 Gdnf 14573   
Peritubular myoid cell 
Sma 11475 calponin 12797 Myh11 17880 
Leydig cell 
3betaHSD 15497 Cyp17a1 13074 Star 20845 
Spermatogonial stem cell 
Thy1 21838 Lin28 83557 Plzf 235320 
Oct4/Pou5f1 18999 Gfra1 14585 Oct2/Pou2f2 18987 
Spermatogonia 
Stra8 20899 Kit 16590 
AP2gamma/
Tfap2c 21420 
Meiotic cells 
Sycp1 20957 Spo11 26972   
Post-meiotic germ cell 
Piwil1 57749     
Cell cycle/Apoptosis 
E2F1 13555 Rb1 19645 Apaf1 11783 
E2F2 242705 Cdkn1b 12576 Fasl 14103 
E2F3a NM_010093.3 Cdkn2b 12579 Trp53 22059 
E2F3b 
NM_00128992
0.1 Ccne1 25729 Bax 12028 
E2F4 104394 Ccne2 12448 Bcl-2 12043 
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Name Gene ID Name Gene ID Name  Gene ID 
E2F5 13559 Ccnd1 12443 Bcl2l2 12050 
p107/Rbl1 19650 Ccnd2 12444 Smad4 17128 
p130/Rbl2 19651 Skp2 27401   
Putative E2F target genes 
Bmp2 12156  13361 Jun 16476 
Fst 14313 Tk1 21877 Cxcr4 12767 
Myc 17869 Junb 16477 Smyd4 319822 
Differentially expressed genes in P10 SC-Rb-/- 8 compared with ChIP-on-Chip 208,209 
Tmem143 70209 Col1a1 12842 Prcp 72461 
Mcm2 17216 Epn1 13854 Scd2 20250 
Mif4gd 69674 Fgd1 14163 Usp1 230484 
Adssl1 11565 Mat2a 232087 Vamp2 22318 
Atf4 11911 Mrps12 24030   
Chek1 12649 Pola2 18969   
Differentially expressed genes in 1.5-month-old  SC-Rb-/- 186compared with ChIP-on-Chip 
208,209  
Cdc6 23834 Pold1 18971 Col4a2 12826 
Ccnb1 268697 Rpa2 19891 Aplp1 11803 
Dnmt1 13433 Rrm1 20133 Aurkb 20877 
H2afz 51788 Rrm2 20135 Cx3cl1 20312 
Clspn 269582 Timeless 21853 Icam1 15894 
Mcm5 17218 Rbbp4 19646 Tgfbi 21810 
Mcm6 17219 Rad51 19361   
Pcna 18538 Brca1 12189   
4.4 Hormone assays (II–IV) 
To measure serum FSH and LH, blood samples from adult male mice were extracted 
immediately after the mice were sacrificed. Serum was obtained by centrifugation, 
and samples were stored at −20℃ until the hormone assays were performed. 
Hormone level quantification was performed using the FSH ELISA Kit (Novus 
Biologicals, Littleton, CO, USA), LH ELISA (Novus Biologicals; II), an 
immunofluorometric assay (III; DELFIA, Wallac, Turku, Finland) 210, or a Luminex 
200 platform using a MILLIPLEX MAP Mouse Pituitary Magnetic Bead Panel (IV; 
Millipore, Burlington, MA, USA).  
To measure the testosterone level in the testis or the FSH and LH content in the 
pituitary, tissue pieces were homogenized and total protein was measured. 
Testosterone level quantification was performed using a Pierce BCA kit (II; Thermo 
Fisher Scientific, Waltham, MA, USA) or a radioimmunoassay kit TESTO-CT2  (III; 
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Cisbio, International, France) 8 according to the manufacturer’s protocol. Moreover, 
the FSH and LH content was detected with the Luminex 200 platform using the 
MILLIPLEX MAP Mouse Pituitary Magnetic Bead Panel (Millipore, Burlington, 
MA, USA). All the obtained concentrations were normalized to the weights of the 
tissues. 
4.5 Fertility (III) 
In each experimental group, male adult mice were bred with females of the same 
genetic background. All breeding couples were kept together for 24 h, or 48 h if no 
copulatory plugs were observed, and the number of pups and sex were recorded. 
4.6 Sperm count (II) 
Sperm were counted from the cauda epididymis of adult mice. All dissected cauda 
epididymides were slightly cut and placed in 1 mL of 1× phosphate-buffered saline 
(PBS) for 30 min. Samples were then pipetted up and down to homogenize the 
solution and to extract most of the sperm, and then 20 µL of each sample was counted 
in a Bürker chamber. Then, the number of sperm was calculated and normalized per 
1 mL of solution. 
4.7 Intracellular flow cytometry (I and III) 
Rat testes were dissected under aseptic conditions and decapsulated in a Petri dish. 
Then, 10 mg of testicular tissue was placed in an Eppendorf tube containing 200 mL 
of an enzyme cocktail (1 mg/mL collagenase/dispase, 1 mg/mL hyaluronidase, and 
1 mg/mL DNase I in Dulbecco’s modified Eagle’s medium/F12) on ice. Testicular 
tissues were then cut using McPherson-Vannas Scissors until small segments of 
1 mm were observed. Then, 800 µL of the enzyme cocktail was added and samples 
were incubated for 30 min at 37℃. Every 5 min during incubation, samples were 
mechanically dissociated by pipetting up and down five times. After incubation, the 
solution was filtered through a 35 µm pore size filter and pelleted at 400 g for 10 min 
at 4℃. To differentiate only live cells in subsequent analyses, LIVE/DEAD (BD 
Falcon, BD Biosciences, NJ, USA) staining was performed. The stock stain was 
reconstituted in dimethyl sulfoxide and added to the sample at a final concentration 
of 1 : 10,000. The product of the LIVE/DEAD staining procedure was then incubated 
for 30 min on ice and pelleted as above.  
Fixation was performed by adding 32% paraformaldehyde (PFA) to a final 
concentration of 4% PFA in the cell suspension under continuous vortexing. Then, 
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samples were incubated for 10 min at 37℃ under gentle rotation. To stop the 
reaction, the samples were placed on ice for at least 1 min and then pelleted by 
centrifugation as above. Permeabilization was performed first by dissolving the 
pellet in 100 µL of PBS and then adding 900 µL of cold 100% methanol under 
vortexing, followed by incubating the samples for 30 min on ice.  
To detect intracellular antibodies, the same steps for common 
immunofluorescence were followed. First, samples were washed once with PBS, 
centrifuged at 1,200 rpm for 7 min at 4℃, resuspended in a blocking solution (0.5% 
normal serum), and incubated for 30 min at room temperature (RT). Primary 
antibodies (Table 3) were diluted in the blocking solution, added to the samples, and 
incubated for 1 h at RT. For antibodies that were not conjugated to fluorophores, 
fluorescence secondary antibodies were used. After primary and secondary antibody 
incubation, all cell suspensions were washed and resuspended in 0.2% bovine serum 
albumin (BSA) and 5 mg/mL RNase in PBS. DNA staining was performed with 
fxCycle or propidium iodide, and then the samples were analyzed using a Fortessa 
LSRII flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). 
4.8 Histology 
Briefly, 4% PFA (I–IV) or  Bouin’s solution (II–IV)-fixed testes were embedded in 
blocks of paraffin. Then, 4–5 µm thick sections were cut and deparaffinized in 
xylene and ethanol series for staining. 
For basic histological analysis, Bouin’s fixed sections were stained with Mayer’s 
hematoxylin, washed, and then counterstained with eosin solution (II, IV) or periodic 
acid–Schiff (III). Before mounting, the slides were dehydrated using an ascending 
gradient of ethanol and xylene. 
4.8.1 Immunohistochemistry (III) 
Briefly, 4% PFA-fixed testis sections were deparaffinized in xylene and descending 
ethanol series. After washing the slides in dH2O, epitopes were exposed by cooking 
the slides in a pressure cooker in 0.1 M citrate buffer (pH 6.0). After cooling down, 
endogenous peroxidase was blocked by incubating the slides in 3% H2O2 for 10 min. 
After washing the slides with 1× Tris-buffered saline (TBS), the sections were 
incubated in normal serum for 1 h at RT to block unspecific bindings. Primary 
antibodies (Table 3) and biotinylated secondary antibodies were incubated for 1 h at 
RT between the washes. Signal detection was performed using 3,3′-
diaminobenzidine chromogen, and counterstaining was performed using Mayer’s 
hematoxylin. As a final step, the slides were dehydrated using an ascending gradient 
of ethanol and xylene and then mounted. 
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4.8.2 RNA in situ hybridization (III) 
Briefly, 4% PFA-fixed testis sections were used to detect the mRNA of E2f3a and 
E2F3ab using a 2-Plex Detection Kit (ACDBio, Newark, CA, USA). Custom and 
control probes were designed by ACDBio. Vulcan Fast Red and black chromogen 
were used to detect the mRNA signals from E2f3a and E2f3ab, respectively. All 
procedures were performed according to the manufacturer’s protocol with some 
modifications. Mayer’s hematoxylin was used as a counterstain. For 
immunohistochemistry coupled to in situ hybridization, the slides were incubated in 
5% horse serum in TBS to block unspecific bindings. Primary antibodies were 
diluted in a blocking solution and incubated overnight at 4℃. Endogenous 
peroxidase was blocked by incubating the slides in 3% H2O2. The signal was detected 
using a biotinylated horse anti-rabbit antibody followed by Vector ABC-HRP 
(Thermo Fisher Scientific, Waltham, MA, USA) staining. The slides were then air-
dried at RT and mounted with EcoMount and then imaged using a Pannoramic MIDI 
FL slide scanner (Zeiss, Oberkochen, Germany). 
4.8.3 Immunofluorescence 
4.8.3.1 Immunofluorescence of paraffin-embedded fixed testes (I–IV) 
In this study, PFA-fixed testis sections were labeled with specific markers to detect 
the number of testicular cell populations, BTB, and cell cycle status of specific cells 
(Table 3), as previously described 8. Briefly, testis sections were deparaffinized in 
xylene and descending ethanol series. After washing the slides in dH2O, epitopes 
were exposed by cooking the slides in a pressure cooker in 0.1 M citrate buffer (pH 
6.0). After cooling down the slides, autofluorescence was blocked by incubating the 
slides in 100 mM NH4Cl for 10 min. Then, after washing the slides with TBS, the 
sections were incubated in 5% normal donkey serum for 1 h at RT to block unspecific 
bindings. Primary antibodies were diluted in a blocking solution (5% normal donkey 
serum) and incubated overnight at 4℃. If the primary antibodies were not conjugated 
to a fluorochrome, secondary antibodies conjugated to a fluorochrome were used. 
After the incubation of the primary antibodies, the slides were washed in 0.05% 
Tween 20 in TBS. Then, the secondary antibodies were diluted in a blocking solution 
and incubated for 1 h at 37℃ in the dark. Notably, 4′,6-diamidino-2-phenylindole 
(DAPI) was used as a counterstain at a concentration of 1 : 10,000 for 5 min. Finally, 
the slides were mounted in a ProLong Diamond Antifade Mountant or 
VECTASHIELD Mounting Medium (Vector Laboratories, Burlingame, CA, USA). 
The sections were then imaged using an AxioImager M1 fluorescence microscope 
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(Zeiss) in the study I or a Pannoramic MIDI FL slide scanner (Zeiss) in the study II–
IV. 
4.8.3.2 Terminal deoxynucleotidyl transferase dUTP nick end labeling 
assay for paraffin-embedded fixed testes (III–IV) 
Apoptotic cells were detected using the terminal deoxynucleotidyl transferase dUTP 
nick end labeling (TUNEL) assay as previously described 8. Briefly, 4% PFA-fixed 
sections were deparaffinized and rehydrated. Then, antigen retrieval was performed 
in a pressure cooker in 0.1 M citrate buffer (pH 6.0). After cooling down the slides, 
autofluorescence was blocked by incubating the slides in 100 mM NH4Cl for 10 min. 
After washing the slides with TBS, the positive control was incubated with grade I 
(3 U/mL) DNase I for 30 min at 37℃. Then, the reaction mixture, containing 
terminal deoxynucleotidyl transferase buffer, transferase, CoCl2, and dUTP, was 
applied to the sections and incubated for 1 h at 37℃ in a humidified chamber. To 
stop the reaction, 300 mM NaCl and 30 mM sodium citrate in Milli-Q water were 
added and incubated for 15 min at RT. Then, after washing with PBS, the sections 
were incubated in 5% normal donkey serum for 30 min at RT. To reveal apoptotic 
cells, extrAvidin was applied to the sections for 30 min at 37℃, followed by washing 
the sections in PBS. Then, DAPI was used as a counterstain at a concentration of 
1 : 10,000 for 5 min. Finally, the slides were mounted in a ProLong Diamond 
Antifade Mountant or VECTASHIELD Mounting Medium (Vector Laboratories). 
The sections were then imaged using an AxioImager M1 fluorescence microscope 
(Zeiss) in the study I or a Pannoramic MIDI FL slide scanner (Zeiss) in the study II–
IV. 
4.8.3.3 Immunofluorescence of testicular cryosections (II) 
Dissected testes were fixed in 4% PFA overnight at RT, dehydrated in 20% sucrose 
solution in PBS, and embedded into an Optimal cutting temperature (OCT) 
compound. Notably, 10 µm thick sections were used for staining (Table 3). Briefly, 
testis sections were deparaffinized in xylene and descending ethanol series. After 
washing the slides in dH2O, epitopes were exposed by cooking the slides in a 
microwave oven in 0.1 M citrate buffer (pH 6.0) for 15–20 min. Then, after washing 
the slides with PBS, the sections were incubated in 5% normal donkey serum and 
5% BSA in 0.2% Tween 20 in PBS (PBST) for 1 h at RT to block unspecific 
bindings. Primary antibodies were diluted in 1% BSA in 0.2% PBST and incubated 
overnight at 4℃. After the incubation of the primary antibodies, the slides were 
washed in 0.1% PBST. Then, the secondary antibodies were diluted in 1% BSA in 
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0.2% PBST and incubated for 1 h at 37℃ in the dark. The slides were then mounted 
in a VECTASHIELD Mounting Medium containing DAPI (Vector Laboratories), 
and the sections were imaged using a Zeiss AxioImager microscope. 
4.8.3.4 Immunofluorescence of whole mounts (II) 
Testes were dissected under aseptic conditions and decapsulated in a Petri dish 
containing cold PBS. Then, the seminiferous tubules were separated carefully and 
then pipetted up and down with a 1 mL with a cut tip several times. The seminiferous 
tubules were transferred to Falcon tubes, which were inverted several times and left 
to sediment on ice. After two washes in PBS, the seminiferous tubules were fixed in 
4% PFA on a rotating table for 4–6 h at 4℃. The samples were left to sediment on 
ice and then washed three times in PBS for 10 min at 4℃, followed by storage at 
4℃ until staining. 
For immunolabeling, whole mounts were blocked with 2% BSA and 10% FBS 
in 0.3% Triton X-100 in PBS (PBSX) on a rotating table for 1 h at RT. Primary 
antibodies (Table 3) were diluted in 1% BSA in 0.3% PBSX and incubated overnight 
at 4℃. After washing with PBSX, secondary antibodies were prepared in 1% BSA 
in 0.3% PBSX and incubated for 2 h at RT in the dark. Notably, DAPI was used as 
a counterstain before mounting the tubules with VECTASHIELD Mounting 
Medium, and common nail polish was used to seal the coverslip. 
4.8.3.5 Whole-mount staining and imaging of the vibratome-sectioned 
testis (IV) 
To show the expression of PLVAP in the testicular blood vessels, we performed 
immunofluorescence staining on vibratome-sectioned testes. Briefly, dissected testes 
were fixed in 2% PFA on ice for 1 h followed by dehydration in an increasing 
methanol series. The samples were dehydrated and kept in 100% methanol at −20℃ 
overnight. On the next day, rehydration was performed in a decreasing methanol 
series and samples were embedded in 4% low-melting-point agarose. Then, 200 µm 
sections were cut using a VT1200 S vibratome (Leica, Wetzlar, Germany). The 
sections were detached from agarose, blocked with 1% BSA and 0.4% PBSX at RT 
for 1 h, and incubated with a primary antibody at 4℃ overnight. After washing, the 
samples were incubated with a secondary antibody at RT for 2 h, and then the 
sections were stained with Hoechst and rinsed with 0.4% Triton X-100. The samples 
were then mounted on glass-bottom well dishes with ProLong Gold without DAPI 
(Thermo Fisher Scientific, Waltham, MA, USA). Then, the sections were imaged 
using a spinning disk confocal microscope (Intelligent Imaging Innovations, 
Göttingen, Germany) equipped with an ORCA-Flash4.0 V2 sCMOS camera 
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(Hamamatsu, Shizuoka, Japan) and C-Apochromat 40x/1.1 objective and using 
SlideBook 6 software (Intelligent Imaging Innovations). 
Table 3.  Antibodies used in the study. 
Target Host Cat. # Manufacturer Application Dilution Study 
Vimentin rabbit 9854 Cell signaling FC, IHC, IF 1/50 I, III 
γH2A2-
Ser139 mouse 05-636 EMD Millipore FC 1/100 I 
Ki67 rat 11-5698-82 eBioscience IHC, IF 1:200-1:400 III, IV 
 rat 14-5698-82 Thermo Fischer IF 1:100-1:400 II 
p130 rabbit sc-317 Santa Cruz IHC 1/800 III 
p107 rabbit sc-318 Santa Cruz IHC 1/1600 III 
E2F3a mouse MS-1063-P0 Thermo Fischer IHC 1/200 III 
E2F3 rabbit sc-878 Santa Cruz IHC 1/1600 III 
AR rabbit sc-816 Santa Cruz IF 1/200 III 
AR rabbit ab133273 Abcam IF 1:100-1:400 II 
ESPIN mouse 611656 BD Biosciences IF 1/400 II, III, IV 
SOX9 rabbit ab5535 EMD Millipore IF 1/400 II, III, IV 
 mouse 53-9765-82 Thermo Fischer IF 1:100 II 
CLDN11 rabbit sc-25711 Santa Cruz IF 1:100-1:400 II, III, IV 
Gata1 rat sc-265 Santa Cruz IF 1:100-1:400 II 
Gata4 goat sc-1237 Santa Cruz IF 1:200 II 
WT1 goat sc-15421 Santa Cruz IF 1:100-1:400 II 
PLZF rabbit sc-22839 Santa Cruz IF 1:100-1:400 II, IV 
USF1 rabbit sc-8983 Santa Cruz IF 1:100-1:400 II 
GFRα1 goat AF560 R&D Systems IF 1:400 II 
DNMT3 mouse IMG-268A Novus Biologicals IF 1:100 II 
3βHSD rabbit KO607 Trans Genic IF 1:200 IV 
CYP11A1 goat sc-18043 Santa Cruz IF 1:200 IV 
SMA mouse ab184675 Abcam IF 1:100 IV 
PNA  RL-1072 Vector Laboratories IF 1:1000 IV 
Scp3 mouse ab97672 Abcam IF 1:200 IV 
CD31 rat 102510 BioLegend FC, IF 1:100 IV 
MECA rat MECA32-17-8 AK 2028/01 InVivo IF 1:100 IV 
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4.9 Human chorionic gonadotropin replacement 
(IV) 
Due to the lack of gonadotropin stimulation, one-week old mice were treated with 
1 UI of human chorionic gonadotropin (hCG, Pregnyl; MSD, Oss, The Netherlands) 
for three weeks. Injections were performed three times a week intraperitoneally. 
Mice were sacrificed at the age of five weeks. Serum samples, testes, and 
epididymides were collected for analysis.  
4.10 Statistical analysis of the data (I–IV) 
All values are presented as mean ± standard error of the mean. All statistical analyses 
were performed using GraphPad Prism 5 software version 6 (GraphPad Software, 
San Diego, CA, USA). The unpaired t-test was used for data with two experimental 
groups (II, IV), and one-way analysis of variance (ANOVA) was used for data with 
three or more experimental groups, followed by Tukey’s test (III). For statistical 
analysis of TruSeq Targeted RNA sequencing, the negative binomial distribution 
model was used. P-values were provided by the TruSeq Targeted RNA sequencing 
application v1.0. P-values less than 0.05 were considered as a threshold for statistical 
significance. 
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5 Results and Discussion 
The following are the main results of studies I–IV: 
I. Intracellular flow cytometry is a newly developed, fast, accurate tool for 
quantifying rodent testicular cell populations. 
II. USF1 is a transcription factor involved in the regulation of the balance 
between self-renewal and differentiation of SSCs. 
III. E2F3 is not essential for adult SC function. However, the interaction 
between pRb and transcription factor E2F3 is involved in the regulation 
of the maintenance of adult SCs in a quiescent state and, therefore, 
determines their function in adult testes. 
IV. PLVAP indirectly regulates the endocrine function of the testis for its 
development and adult function. 
5.1 A rapid intracellular flow cytometry protocol to 
study rodent testicular dynamics (I) 
Various morphometric methods, such as manual quantification, of stained tissues or 
cells have been conventionally used in routine laboratory analyses. When studying 
the testis, immunohistochemistry and immunofluorescence staining are considered 
helpful in the identification of specific cell types. However, using morphometric 
techniques in a heterogeneous organ like the testis is laborious and time-consuming. 
Thus, using flow cytometry technology to study testicular populations coupled to 
DNA staining and/or specific antibodies has improved the screening of testicular cell 
composition 137–140. Unlike previously reported protocols, we proposed a flow-
cytometry-based protocol that allows quick assessment of rodent testis phenotype in 
one working day.  
5.1.1 Protocol development and optimization 
The principal goal of this study is to develop an accurate and fast flow-cytometry-
based method for the analysis of testicular cell populations. As we wanted to obtain 
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information on different types of cell populations, signaling cascades, and molecular 
pathways, we opted to develop a protocol suitable for fluorescent intracellular 
antibody detection. While developing our method, we used rat testis ontogenesis as 
a model (5, 10, 16, and 24 days old and adult rats) as the testicular composition and 
maturation at different time points are well characterized 211,212.  
Testicular single-cell suspensions are prepared in four steps: mincing of the 
tissue, enzymatic/mechanical dissociation, fixation, and permeabilization (I; Figure 
1). The enzymatic and mechanical step was optimized step by step to obtain 
representative testicular cell population ratios (I; Figure 1) that mimic the natural cell 
dynamics during rodent testicular development. To avoid the destruction of fragile 
pachytene spermatocytes, the maximum number of mechanical pipetting steps 
during enzymatic incubation was set to five. Fixation and permeabilization of the 
cell suspension are considered critical steps to use intracellular antibodies, for which 
we used 4% PFA and cold methanol, respectively. This protocol enables the storage 
of testicular single-cell suspensions for long periods of time at −20℃. If needed, 
these suspensions can also be delivered to other laboratories for further staining and 
analysis. 
To distinguish the heterogeneous cell populations in our single-cell suspension, 
we used propidium iodide or fxCycle as a DNA stain. Flow cytometry analysis 
showed that we recovered representative amounts of testicular cell populations. In 
rats that are 5–16 days old, the testicular cell suspension was found to consist of 2C 
cells in the S-phase of the cell cycle and 4C populations. Notably, the ratio of 2C 
(SCs, spermatogonia) to 4C (primary spermatocytes) populations was found to 
change when 1C (spermatids) cells were observed in the testes of 24-day-old rats. 
By the time the animal reaches adulthood, the 1C population becomes predominant 
in comparison to the 2C and 4C populations (I; Figure 3). According to these results, 
the cell number rates in different cell populations obtained by our optimized protocol 
were found to be similar to those in previous morphometric studies 211,216. 
5.1.2 Intracellular antibody staining 
To confirm the presence of representative populations and to gather more 
information about the somatic/germ cell dynamics, we optimized the fluorescence 
intracellular staining technique to the obtained single-cell suspension. We used 
vimentin antibody (expressed in SCs and Leydig cells) to monitor the somatic cells 
of the testis and phosphorylated γH2AX antibody to detect germ cells. After 
intracellular antibody staining, the single-cell suspension was counterstained with a 
DNA stain and analyzed using flow cytometry. 
The expression of vimentin was found to mimic the proliferation dynamics of 
somatic cells during rat testicular development 211,213 (I; Figure 4). Before 
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spermatogenesis, the composition of the rat testis consisted mostly of SCs and 
spermatogonia. As expected, the rat testicular cell population at the ages of 5 and 10 
days was found to consist mostly of vimentin-positive cells. At the age of 16 days, 
the proportion of vimentin-positive cells starts to decrease as the proliferation of SCs 
gradually ceases to form the BTB, and spermatogonia begin to proliferate. From the 
age of 24 days, when the first haploid cells emerge, to the adult age, the relative 
abundance of vimentin-positive cells decreases as the seminiferous tubules consist 
mostly of germ cells at different differentiation steps (I; Figure 4). This protocol is 
considered to be helpful in recovering a representative amount of somatic cells of 
young and adult testes. 
In the testis, phosphorylated γH2AX histone protein is associated with both DNA 
double-stranded breaks and sex vesicle formation. This protein is expressed in germ 
cells from differentiated spermatogonia (2C) to pachytene spermatocytes (4C) and 
in steps 11 to 14 in RSs (1C) 214,215. From our results, at the age of 16 days, most of 
the testicular cells were negative for γH2AX, because somatic cells were undergoing 
proliferation, and undifferentiated spermatogonia were present (I; Figure 5). As 
expected, most of the 4C populations were positive for γH2AX staining in the adult 
testis (I; Figure 5). These results prove that this antibody can be useful in the 
detection of specific subsets of germ cells in rodents. 
Despite the broad availability of antibodies on the market, validation of 
immunofluorescence staining for flow cytometry analysis is challenging because 
many antibodies do not share the same staining protocols. Our aim was to use 
multiple antibodies at once; however, some of the antibodies (PLZF, SOX9, SMA, 
KI67, and protamine 2) did not perform as expected. This phenomenon may be 
related to the fixation and permeabilization steps that alter the target epitopes. 
Additionally, interspecies differences may have limited the performance of these 
antibodies, restricting the availability and use of suitable antibodies among rodents.  
Despite the advantages of our method and the large number of cells that can be 
analyzed using a flow cytometer, this method cannot replace the golden-standard 
histological analysis. However, our approach can provide much more targeted 
information to understand and complement histological data. 
5.1.3 Application of the flow-cytometry-based method 
Since the publication of the flow-cytometry-based method, it has been adapted to be 
used with different amounts of rat and mouse testicular tissues (Table 4). 
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Table 4.  Application of the flow cytometry protocol in additional projects.  
Studies Specie Analyzed tissue Staining 
Eggert A., Cisneros-Montalvo S., Anandan S., Musilli S., 
Stukenborg J.B., Adamsson A., Nurmio M., Toppari J. 
2019. The effects of PFOA (Perfluorooctanoic acid) on 
fetal and adult rat testis. Reprod Toxicol. 11;90:68-76. 
Mouse 20 pieces of 2 
mm 
seminiferous 
tubules were 
pooled per 
sample 
Vimentin 
and 
DNA 
staining 
Hakkarainen, J., Zhang F.P., Jokela H., Mayerhofer A., 
Behr R., Cisneros-Montalvo S., Nurmio M., Toppari J., 
Ohlsson C., Kotaja N., Sipila P., and Poutanen M. 2018. 
Hydroxysteroid (17beta) dehydrogenase 1 expressed 
by Sertoli cells contributes to steroid synthesis and is 
required for male fertility. Faseb J. 32:3229-3241. 
Mouse 10mg of testis 
tissue per 
sample 
DNA 
staining 
Reda, A., Albalushi H., Montalvo S.C., Nurmio M., Sahin 
Z., Hou M., Geijsen N., Toppari J., Soder O., and 
Stukenborg J.B. 2017. Knock-Out Serum Replacement 
and Melatonin Effects on Germ Cell Differentiation in 
Murine Testicular Explant Cultures. Ann.Biomed.Eng. 
45:1783-1794. 
Mouse 3-5 mg of testis 
tissue per 
sample 
DNA 
staining 
Rotgers, E., Nurmio M., Pietilä E., Cisneros-Montalvo 
S., and Toppari J. 2015. E2F1 controls germ cell 
apoptosis during the first wave of spermatogenesis. 
Andrology. 3:1000-1014. 
Mouse 10mg of testis 
tissue per 
sample 
DNA 
staining 
 
5.1.4 Update and future perspectives (I) 
Notably, after we published our protocol, we succeeded in downscaling it, allowing 
us to analyze only a few milligrams of testis tissues 217 and even pieces of the 
seminiferous tubules 218 (Table 4.). Our protocol can be used for quick screening of 
testicular phenotypes of transgenic animals and testicular effects of in vivo drug 
exposure, and it can also be used to study the cell dynamics of in vitro cultures of 
seminiferous tubule pieces. Recently, we have added the phospho-histone H3 
(Ser10) antibody to our antibody panel to analyze mitotic and meiotic progression 
during testicular development. 
In the future, further optimization of a larger panel of specific antibodies would 
provide additional information on somatic and germ cell dynamics and signaling 
pathways during testicular development and spermatogenesis, which would have 
significant potential in several clinical applications, such as the characterization, 
diagnosis, and monitoring of disorders of human male reproduction. 
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5.2 USF1 is required for the maintenance of 
spermatogonial stem cells (II) 
USF1 is a ubiquitously expressed transcription factor that has been reported to 
participate in biological processes from lipid to glucose metabolism pathways. 
Despite its reported expression in only the supporting cells of the testis, no essential 
function has been found for USF1 in male fertility. In this study, we demonstrated 
that USF1 is also expressed in SSCs and plays a crucial role in male fertility. 
5.2.1 Testicular phenotype of Usf1−/− (II) 
It was observed that the loss of USF1 produces a significant decrease in body and 
testis weight in mice aged 1 to 20 weeks (II; Figures 2A–2C). In addition, a 
significant difference was observed in the relative testis weight (testis weight/body 
weight) in 1, 12, and 20-week-old mice with Usf1−/− testes (II; Figure 2D). At the 
age of 1–8 weeks, histological analysis of the Usf1−/− testis showed a normal 
seminiferous tubule architecture; however, the testis atrophied gradually by 12 
weeks of age (II; Figure 2E). At this time point, some seminiferous tubules display 
complete spermatogenesis, while others consist of fewer spermatogenic layers or an 
SC-only phenotype. To evaluate the spermatogenic defect level in Usf1−/−, we 
quantified the number of tubule cross sections with empty tubules or those lacking 
one to three spermatogenic cell layers at different time points. As a result, Usf1−/− 
testes showed a larger number of tubule cross sections missing one to three 
spermatogenic cell layers and empty tubule cross sections from eight weeks old 
onwards (II; Figures 2K–2N) in comparison to the control animals. Notably Usf1−/− 
mice were initially fertile with sperm counts similar to those of the controls at the 
age of eight weeks; however, similar to the histological findings, the sperm count in 
12-week-old mice was found to be significantly lower than in the controls (II; 
Supplementary Figure 3C). Serum FSH and LH were found to be significantly high 
in Usf1−/− mice, which is a sign of failure of the testes. Notably, the level of ITT, but 
not that of serum testosterone, was also found to be significantly higher in Usf1−/− 
mice than in the control animals (II; Figures 3A–3D). According to these data, the 
testes of Usf1−/− mice show age-related degeneration of the seminiferous epithelium, 
resulting in a decrease in sperm production. Besides, the testicular phenotype appears 
not be caused by insufficient gonadotropin stimulation or lack of androgen 
stimulation. 
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5.2.2 Somatic cell status in Usf1−/− (II) 
To evaluate the protein expression of USF1 in a control testis, we performed indirect 
immunofluorescence in PFA-fixed sections. Notably, a strong signal was detected in 
SCs and a weak signal was detected in interstitial cells (II; Figure 1C). To evaluate 
the possible dysfunctional status of somatic cells, immunofluorescence staining was 
performed with specific markers, in addition to further quantification of positive 
cells. SOX9 and 3β-HSD antibodies were used as specific markers for SCs and 
Leydig cells, respectively. KI67 antibody, a proliferation marker, was also added to 
the assay to provide information regarding the proliferation status of somatic cells in 
the Usf1−/− testes at different time points. Quantification revealed that the number of 
SCs (SOX9-positive) and Leydig cells (3β-HSD-positive) in proliferation per cross 
section in the Usf1−/− testes is similar to that of the control mice at 4, 8, and 12 weeks 
of age (II; Supplementary Figure 4A, Figures 3E and 3F). The normal relative 
amount of Leydig cells in the Usf1−/− does not explain the high ITT levels. However, 
it may be partially explained by the higher ratio of Leydig cells to the other cell types 
present in the degenerating testis. Furthermore, AR, which is essential for lifelong 
fertility, showed a similar mRNA and protein expression in both the Usf1−/− and 
control testes (II; Figure 3H). Also, immunofluorescence of ESPIN and CLAUDIN 
11, which are components of the BTB that also reflect the terminal differentiation of 
SCs, did not show any differences between the control and Usf1−/− testes (II; 
Supplementary Figures 4F and 4G). Collectively, these data suggest that the Sertoli 
and Leydig cell cycle dynamics are not altered in Usf1−/− testes.  
As it has been reported in previous studies that USF1 and USF2 have 
compensatory functions in the absence of one of them 159,224, the unaltered Leydig 
cell and SC development in Usf1−/− mice may be due to USF2 compensation in the 
absence of USF1. Therefore, Sertoli/Leydig cell-specific knockout models would be 
beneficial to evaluate the extent of compensation and the effect of Usf1 deletion at a 
transcriptomic level. 
5.2.3 USF1 is expressed in spermatogonial stem cells in the 
testis 
As low-level protein expression is difficult to detect by immunofluorescence in 
standard PFA-fixed testis sections, indirect immunofluorescence staining of USF1, 
SOX9, PLZF (expressed in undifferentiated, progenitor, and early differentiating 
spermatogonia), and DNMT3 (expressed in A1–A4, In, B, and preleptotene 
spermatocytes) antibodies was performed in fixed whole-mount samples. Notably, 
USF1 protein expression was detected, as previously shown, in SCs (SOX9 and 
USF1 double-positive cells) and also in spermatogonia (PLZF and USF1 double-
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positive cells), and a higher signal of USF1 was detected from PLZF-positive, 
DNMT3A-negative cells. Further characterization using immunofluorescence 
revealed that USF1-positive undifferentiating spermatogonia also express GFRα1, a 
marker of As and Apr SSCs (II; Supplementary Figure 1A; Figures 1D and 1E). 
5.2.4 USF1 regulates the self-renewal of spermatogonial 
stem cells (II)  
As USF1 protein expression was detected in spermatogonia, we evaluated whether 
the population of spermatogonia is affected in Usf1−/− testes using indirect 
immunofluorescence with PLZF antibody. Quantification of PLZF-positive cells in 
the Usf1−/− testes showed significant depletion of this population from the age of 
eight weeks onwards (II; Figure 5B).  
As apoptosis and overproliferation are the principal causes of germline stem cell 
depletion, we evaluated these alternatives using immunofluorescence in fixed whole-
mount seminiferous tubules. Notably, cleaved caspase-3 staining did not show 
increased apoptosis within GFRα1-positive cells (a marker of As and Apr 
spermatogonia) in Usf1−/− adult testes (II; Supplementary Figure 8). However, when 
the proliferation rate within the GFRα1-positive cells was quantified, clear 
differences were observed in the seminiferous tubules of the Usf1−/− mice. A 
significantly large number of proliferating As undifferentiated spermatogonia were 
observed in the seminiferous tubules of Usf1−/− mice. Furthermore, a large, but 
insignificant, number of proliferating Apr undifferentiated spermatogonia were 
observed in the seminiferous tubules of Usf1−/− mice (II; Figures 6A–6D). These 
results suggest that the failure of spermatogenesis observed may be attributed to the 
continuous proliferation of As and, as a consequence, the gradual exhaustion of the 
SSC pool. 
In normal spermatogenesis, a subpopulation of SSCs exit the cell cycle and a 
subset of them delineate into a differentiation-primed state to give rise to more 
differentiated germ cells. In the case of Usf1−/−, As spermatogonia do not exit the cell 
cycle, causing gradual exhaustion of the SSC pool at the adult stage. This may 
explain why Usf1−/− testes at a young age display normal-looking spermatogenesis 
but fail to maintain spermatogenesis with age. This type of failure has also been 
reported in other mouse models, including mice deficient in Plzf 35,36, Ta4b 37, and 
Erm 219, which are fertile at a young age but then their seminiferous tubules start to 
gradually lose their capacity to maintain steady spermatogenesis. 
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5.2.5 Gene expression analysis 
We evaluated the mRNA levels from whole testes of important paracrine factors 
(Cxcl12, Csf1, Fgf2, Nrg1, Wnt4, Wnt5a, Wnt6, and Bmp4) that determine the mouse 
testis stem cell niche integrity. However, no significant differences were found at 
any of the time points evaluated in comparison to the controls (II; Supplementary 
Figures 6 and 7). As Gdnf and Scf are very important for the differentiation of 
spermatogonia, we evaluated the mRNA expression of them also in isolated stage-
specific seminiferous tubules from Usf1−/− and control testes. We observed a 
significantly increased level of Gdnf at stages II–V as well as an increased level of 
Scf at stages VII and VIII in comparison to the controls (II; Figures 5C and 5D). As 
Gdnf is related to the mitotic status of undifferentiated spermatogonia and its levels 
are low in these stages in WT testes 220–222, we hypothesized that Gdnf contributes to 
the continuous proliferation of As spermatogonia in Usf1−/− testes. Besides, as Gdnf 
is regulated by FSH 223, the high levels of FSH observed in the plasma of Usf1−/− 
mice may contribute to the elevated levels of Gdnf in the testis. Collectively, these 
results suggest that the paracrine milieu of the SSC niche in Usf1−/− testes is similar 
to the one in the controls. However, the overexpression of Gdnf may contribute to 
the continuous proliferation of As spermatogonia in Usf1−/− testes. 
5.2.6 Future perspective (II) 
Previously, the USF1 transcription factor has been reported to be expressed only in 
the supporting cells of the testis, the SCs. However, in our study, indirect 
immunofluorescence of USF1 in whole fixed seminiferous tubules revealed that 
USF1 is also expressed in SSCs and undifferentiated spermatogonia. This expression 
pattern resembles that of PLZF, a routinely used marker for undifferentiated 
spermatogonia. Thus, USF1 is regarded as a potential marker of undifferentiated 
spermatogonia. 
During our study, we made use of a global Usf1 knockout model, which makes 
difficult the interpretation of direct cell-specific or indirect effects from other cells 
or organs. Despite the fact that, not alteration was observed in the proliferation and 
maturation of the somatic cells in the Usf1−/−, it can not be discarded the possibility 
of a gradual failure in function after their maturation. In such a situation, 
somatic/germ cell specific knockout models would be beneficial to evaluate the 
effect of the absence of Usf1 in specific cell types. The molecular mechanism by 
which the deficiency of Usf1 causes continuous proliferation of undifferentiated 
spermatogonia has not been addressed in this study. Therefore, further research is 
needed on this subject as the control of self-renewal and differentiation of stem cells 
may have a potential future clinical application in cancer stem cell treatment. 
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Mice with inactivated USF1 gene show improved lipid profile. Therefore, it has 
been reported that USF1 is a potential target for diabetes, obesity, and other 
cardiometabolic diseases 6. In our study, we showed that complete deletion of USF1 
is not useful for male fertility in the long run. However, haploinsufficiency of Usf1 
would be a good option as a therapeutic target because heterozygous mice also 
exhibit good lipid profiles with no alteration in testicular development and function 
6. 
5.3 RB/E2F3 is required for the terminal 
differentiation of Sertoli cells (III) 
We have previously reported the role of RB in the maintenance of adult mouse SCs 
in a quiescent stage. We also showed that RB interacts with E2F3 to maintain adult 
SCs in a quiescent state and that shRNA-mediated knockdown of E2f3 partially 
recovers the phenotype 8. In this study, we revealed the dispensable function and 
expression pattern of E2F3 during SC development. In addition, through SC-specific 
deletion of Rb and E2f3 simultaneously, we obtained complete recovery of the 
phenotype and further unraveled the RB/E2F3 interaction in the adult SCs. 
5.3.1 E2F3 expression in mouse testis (III) 
To study the expression of both E2F3 isoforms in SCs, we performed 
immunohistochemistry staining of E2F3a and E2F3ab antibodies at the age of 6, 10, 
20, and 40 days in control testes. It was found that the E2F3a protein is expressed in 
a subpopulation of SCs in the testes of six-day-old mice. Notably, the number of SCs 
positive for E2F3a increased with age until the age of 20 days when all SCs were 
positive for E2F3a (III, Figure 1A). To evaluate whether the expression of the E2F3a 
isoform is associated with the engagement of SC differentiation, we performed 
immunohistochemistry of KI67 together with the E2F3a antibody. However, no 
correlation was observed in the KI67 and E2F3a staining, as both double E2F3a-
positive/KI67-positive and E2F3a-positive/KI67-negative SCs were detected (III, 
Figure 1A). It was also observed that the expression pattern of E2F3ab is similar to 
that of E2F3a in SCs. However, in the testes of mice aged 6 and 10 days, E2F3ab 
was also found to be expressed in spermatogonia (III, Figure 1B). Collectively, these 
data show that both E2F3 isoforms are expressed with different patterns: the 
expression of E2F3a is gradual in SCs but not linked to the cell cycle exit of SCs 8,225 
and the expression of the E2F3b isoform is exclusive in the spermatogonia of young 
testes. 
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5.3.2 E2F3 is not required for mouse testicular development 
and function (III) 
To evaluate the role of E2f3 in mouse SCs, a mouse model in which the expression 
of E2f3 is absent from SCs (SC-E2f3−/−) was studied. Despite the loss of E2f3, these 
SC-E2f3−/− mice did not face any problems during development. Their relative testis 
weight (testis weight/body weight) did not show a significant difference at the age 
of two months (III; Supplementary Figure 1A) in comparison to the controls. At the 
age of five months, their relative testis weight became significantly smaller; 
however, they sired healthy pups and no significant differences were observed in the 
number of pups per litter as compared with the control males (III; Table 1). 
Histologic analysis of the SC-E2f3−/− testis did not show any alteration in the 
seminiferous architecture at either age (III; Supplementary Figure 1C). 
To evaluate whether this small relative testis size was due to increased apoptosis 
in the SC-E2f3−/− testes, TUNEL staining was performed. However, the SC-
E2f3−/− testes were found to have an apoptotic index similar to that of the control 
mice (III; Supplementary Figure 1E). Furthermore, flow cytometry analysis 
confirmed that the number of testicular cell populations according to their DNA 
content in the SC-E2f3−/− testes was similar to that of the control mice (III; 
Supplementary Figure 1D). Collectively, these data indicate that E2f3 is redundant 
in SCs. Notably, SC-E2f3−/− mice showed normal testicular development and 
fertility compared to those of the control mice. As a compensatory function has been 
reported among the E2F transcription factors 226, we proposed that the status of SCs 
was not compromised in SC-E2f3−/− most probably by a compensatory effect by 
other E2F transcription factors. 
5.3.3 The testicular phenotype of the SC-Rb−/−E2f3+/+, 
SC-Rb−/−E2f3+/− and SC-Rb−/−E2f3−/− mice (III) 
We obtained an SC-Rb−/−E2f3+/+ and SC-Rb−/−E2f3−/−  mouse lines in which the 
SCs lack Rb or Rb and E2f3 expression, respectively. Despite having a different 
genetic background, this mouse line had a phenotype similar to the one described 
before, in which SC-Rb−/− mice display impaired testicular function due to adult SC 
dysfunction 8,186. We previously showed that knocking down E2f3 with shRNA in 
the absence of Rb partially restores the seminiferous tubule architecture of SC-
Rb−/−. Thus, to investigate whether double knockdown of Rb and E2f3 in SCs would 
fully restore the infertility phenotype, we studied the SC-Rb−/−E2f3+/+ mouse line.  
As expected from previous studies 8, the relative testis weight (testis weight/body 
weight) of SC-Rb−/−E2f3+/+ mice was found to be significantly lower than that of 
the control mice. Moreover, the relative testis weights of E2f3-haploinsufficiency 
(SC-Rb−/−E2f3+/−) and E2f3-KO (SC-Rb−/−E2f3−/−) mice were found to be 
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comparable to those of the control mice (III; Figure 2A). Fertility test showed that 
male SC-Rb−/−E2f3+/+ mice were infertile as only immature germ cells were 
detected in the cauda epididymis, and they were not able to sire pups (III; Figure 5A, 
Table 1). On the contrary, the cauda epididymis of SC-Rb−/−E2f3+/− and SC-
Rb−/−E2f3−/− mice showed mature sperm, and they were able to sire pups, though 
not comparable to the controls (III; Figure 5A, Table 1). Histological analysis of 
testis reflected the epididymal and fertility test findings. The seminiferous tubule 
architecture of the SC-Rb−/−E2f3+/+ testis was found to be atrophied at the age of 
2.5 months. Empty seminiferous tubules or seminiferous epithelia with few cells or 
layers were abundant. Notably, the phenotype of E2f3-haploinsufficiency (SC-
Rb−/−E2f3+/−) mice was found to be partially recovered as most tubules exhibited 
full spermatogenesis; however, few tubules still exhibited altered spermatogenesis. 
However, the double knockdown of Rb and E2f3 in SCs fully restored the infertility 
phenotype of the SC-Rb−/−E2f3+/+. Similar to the controls, the seminiferous tubules 
displayed complete spermatogenesis.  
These data indicate that the deletion of both alleles of E2f3 in the absence of Rb 
was able to fully recover the phenotype as they consisted of seminiferous tubules 
with full spermatogenesis similar to the control mice (III; Figure 2B). 
5.3.4 E2F3 induces cell cycle reentry in adult Sertoli cells in 
the absence of retinoblastoma protein (III) 
According to our previous study, adult SCs in SC-Rb−/− reenter the cell cycle and 
cannot support spermatogenesis 8. To evaluate whether the double deletion of Rb and 
E2f3 restores the status of adult SCs, indirect immunofluorescence of SOX9 (a 
marker of SCs) and KI67 was performed at the age of 2.5 months.  
It was found that the SC-Rb−/−E2f3+/+ testis had a significantly higher rate of 
adult SCs in proliferation than the control mice. One E2f3 allele was able to induce 
SC proliferation in the adult testis in the absence of Rb (SC-Rb−/−E2f3+/−). 
Nevertheless, the deletion of both E2f3 copies was able to block ectopic 
proliferation, as the proliferation rate decreased to the same level as in the testis of 
the control animals (III; Figures 3A and 3B). This recovery system has also been 
reported in a Drosophila model by Greenspan et al. 227. The lack of Rbf (Drosophila 
homolog of RB) in the hub cells of the testis was found to induce cell cycle reentry 
and the formation of ectopic stem cell niches. Moreover, the phenotype was rescued 
by the knockdown of E2F. Besides, E2f3 deletion was also found to rescue the 
proliferation defect in lens and cells from the central nervous system 228 and pituitary 
tumors 229 lacking Rb. Our results and reported data indicate a conserved role of RB-
E2F in the control of a quiescent status. To evaluate the terminal differentiation 
status of adult SCs, we performed immunofluorescence staining of CLAUDIN 11 
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and ESPIN, which are components of the tight junctions and ectoplasmic 
specializations of the BTB. The results showed that the BTB of the SC-
Rb−/−E2f3+/+ testis was disrupted. In line with the observation described above, 
SC-Rb−/−E2f3−/− mice were found to have a normal BTB and ectoplasmic 
specialization (III; Figure 5B). To evaluate whether the active proliferation of SCs 
in SC-Rb−/−E2f3+/+ was related to cell transdifferentiation, FOXL2 
immunofluorescence staining was performed as granulosa cells in the ovary are 
positive for this protein. However, the adult SCs in SC-Rb−/−E2f3+/+ did not yield 
any FOXL2-positive signal (III; Supplementary Figure 2). 
Collectively, these data indicate that the double deletion of Rb and E2f3 was able 
to restore the quiescent status of adult SCs and also the abnormal BTB seen in the 
SC-Rb−/−E2f3+/+ testis. As RB and E2F3 physically interact in SCs  8, RB/E2F3 
may be associated with SC differentiation to an adult phenotype. Moreover, RB is 
probably recruited by E2F3a to silence genes related to proliferation or induce gene 
transcription associated with maturation. 
5.3.5 Gene expression analysis (III) 
The mRNA expression levels of the selected proteins were measured from whole 
testes at the age of 2.5 months. In the Rb−/− fetal testis, p27 (CDK inhibitor 1B) 
compensates the lack of Rb and SKP2 (S-phase kinase-associated protein 2) inhibits 
p27 by proteasomal degradation 184; therefore, we evaluated whether this 
compensation also occurs in our mouse lines. However, no significant changes in the 
expression level of p27 between the experimental groups and the control mice were 
observed. However, the expression level of Skp2 was found to be significantly 
downregulated in the SC-Rb−/−E2f3+/+ testes, and expression was restored in SC-
Rb−/−E2f3−/−, suggesting that this compensatory mechanism also operates in the 
adult testis (III; Figures 3C and 3D).  
Despite the active proliferation of adult SCs in the SC-Rb−/−E2f3+/+ testes, they 
seemed to maintain a transcriptional program similar to that of mature SCs, as the 
expression levels of Wt1, Sox9, Gata1, and Gdnf remained unaffected (III; Figure 
3E). Moreover, as no SC tumors were visible, we also evaluated the pro- and 
antiapoptotic Trp53 and Bcl-2 expression levels. It was observed that the expression 
level of Trp53 did not change in the SC-Rb−/−E2f3+/+ testes, but it significantly 
decreased in the SC-Rb−/−E2f3−/− testes (III; Figure 4D). Besides, a significantly 
decreased expression of pluripotency factors, such as Oct4, Lin28, and Gfra1, for the 
stem cell niche function was observed in the SC-Rb−/−E2f3+/+ testes and finally 
restored in the SC-Rb−/−E2f3−/− testes (III; Figure 4E). 
Follistatin (Fst) is an E2F target gene that is highly expressed in immature testes, 
whose expression decreases as the animal reaches adulthood 79. In our model, the 
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mRNA expression of Fst was found to vary depending on the E2F3 status. Namely, 
it is highly induced in SC-Rb−/−E2f3+/+ mice and decreased in the SC-
Rb−/−E2f3−/− mice, suggesting that RB-E2F3 inhibits the expression of Fst in WT 
testes. Interestingly, overexpression of Fst in the testis results in alterations in the 
seminiferous tubule architecture similar to those in SC-Rb−/−E2f3+/+ and SC-
Rb−/−E2f3+/− mice 230. In our model, the high expression of Fst in the SC-
Rb−/−E2f3+/+ mice could have contributed to the SC dysfunction. However, as FST 
inhibits activin A and activin B, which promote SC proliferation 231, increased Fst 
expression could have been a consequence to the cell cycle reentry of adult SCs. 
5.3.6 Future perspectives (III) 
Traditionally, it has been thought that adult SCs are permanently quiescent and 
terminally differentiated. However, it has been suggested that, instead, they may be 
arrested proliferating cells. This is because mouse and human adult SCs have been 
reported to resume proliferation in culture 232 and to show the expression of several 
DNA repair proteins after irradiation, such as XRCC1 and PARP1, a phenomenon 
that has not been observed in other quiescent cells 232–235. RB-E2F3 may participate 
in arrested proliferation, but still more studies need to be performed. Furthermore, 
unknown RB-binding partners to control the proliferation or differentiation of SCs 
may yet be found. 
Among RB and E2F family proteins, functional compensation is observed 
because they share the same consensus DNA-binding sequence 236. For example, in 
our SC-Rb−/−E2f3+/+ mice, ectopic expression of p107 was observed in adult SCs, 
which makes the study of the functions of a specific RB or E2F protein in vivo 
challenging. 
5.4 Endothelial-specific plasmalemma vesicle-
associated protein is needed for normal 
testicular development (IV) 
Previous studies have reported the role of PLVAP in microvasculature permeability, 
leukocyte migration, angiogenesis of blood vessels, and seeding of fetal monocyte-
derived macrophages to different tissues in mice 9,195,196,199,237,238. However, the 
function of PLVAP in male fertility has not yet been assessed. In this study, using 
the Plvap−/− mouse line, we demonstrated that PLVAP is expressed in the testicular 
vasculature of WT adult testes and plays a crucial role in normal testicular 
development and function. 
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5.4.1 Testicular phenotype of Plvap−/− (IV) 
Loss of PLVAP produces a significant decrease in body weight, testis size, and 
relative testis weight (mg/g) of Plvap−/− mice at five weeks of age in comparison to 
the control mice (IV; Figures 1A–1C). Histological analysis of the testis revealed an 
abnormal seminiferous tubule architecture in the Plvap−/− testis at five weeks of age. 
Most of the seminiferous tubule cross sections displayed incomplete 
spermatogenesis with a reduced number of germ cells and absence of ES layer (IV; 
Figure 2A). Therefore, it was challenging to identify specific seminiferous 
epithelium stages. To evaluate whether the germ cell loss in the Plvap−/− testis is due 
to increased apoptosis, TUNEL staining analysis at five weeks of age was performed. 
Notably, the Plvap−/− testis showed a significantly increased rate of germ cell 
apoptosis that may contribute to the loss of differentiating cells and smaller testis 
size in comparison to the control testis (IV; Figures 3A–3C). In line with the 
observations described above, the cauda epididymis histology of the Plvap−/− testis 
at five weeks of age only showed immature germ cells (IV; Figure 2C). 
Consequently, the Plvap−/− mice were found to be infertile at the age of five weeks. 
These data indicate that loss of Plvap affects testicular development and impairs 
spermatogenesis. 
5.4.2 Abnormal proliferation of somatic cells in adult Plvap−/− 
mouse testes (IV) 
To evaluate whether the abnormal proliferation dynamics of testicular somatic cells 
is the reason for the decreased testis size and arrested spermatogenesis in the adult 
Plvap−/− mice, we used immunofluorescence to evaluate the proliferation rate and 
number of PTMs, SCs, and Leydig cells at different time points. 
Immunofluorescence staining of the α-SMA antibody (a PTM marker) together 
with KI67 (a proliferation cell marker) antibodies showed that the proliferation rate 
of PTMs in the Plvap−/− testes does not change at the age of one week in comparison 
to the control testes. At two weeks of age, the proliferation rate of PTMs in the 
Plvap−/− testes was found to be significantly lower than in the control testis. 
Interestingly, the proliferation rate of PTMs in the Plvap−/− testes at the age of five 
weeks was found to be significantly increased in comparison to the control testes 
(IV; Figures 5A and 5B). Additionally, the proliferation rate and number of SCs were 
also evaluated at the same time points. The only significant difference observed in 
the proliferation rate between the Plvap−/− and control testes was at the age of two 
weeks (IV; Figures 5C and 5D). Besides, the BTB integrity observed by ESPIN and 
CLAUDIN 11 immunostaining showed that their protein expression pattern in 
Plvap−/− is comparable to that of the control mice (IV; Supplementary Figure 2). 
Despite the abnormal proliferation of SCs in the Plvap−/− testes, their maturation was 
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not affected as the SCs were quiescent and able to form a BTB at the age of five 
weeks.  
To evaluate whether the proliferation rate and number of Leydig cells were 
altered in the Plvap−/− testes, we performed immunostaining of 3β-HSD (a marker 
for Leydig cells) and KI67 antibody at two and five weeks of age. Quantification of 
Leydig cells in proliferation (3β-HSD+KI67+ cells) showed that the proliferation 
rate was affected in the Plvap−/− testes at the age of two weeks. However, similar to 
SCs, the number of Leydig cells per cross-sectional area was comparable to that in 
the control mice at the age of five weeks (IV; Figure 6A–6C). These results indicate 
that the proliferation dynamics of somatic cells are altered in Plvap−/− testes. 
5.4.3 The testicular phenotype of the Plvap−/− adult testis is 
due to insufficient gonadotropin stimulation (IV) 
To evaluate whether the pituitary hormone level contributed to the testicular 
phenotype, the levels of LH and FSH in the serum and pituitary were measured. 
Notably, Plvap−/− mice were found to have significantly decreased LH and FSH 
serum levels in comparison to the control mice (IV; Figures 8A and 8B). 
Interestingly, the intrapituitary hormone levels were also found to be significantly 
lower in the Plvap−/− testes at the age of five weeks (IV; Figures 8C and 8D). 
Collectively, these data indicate that the testis phenotype in Plvap−/− mice is likely 
due to insufficient gonadotropin stimulation. 
5.4.4 Hormonal replacement therapy recovered the Plvap-/- 
phenotype partially (IV) 
Hormonal replacement therapy was performed at the age of one to five weeks to 
evaluate the contribution of hormone deficiency to the testicular phenotype of 
Plvap−/− mice. Plvap−/− mice and controls were injected with 1 U of hCG three times 
a week.  
According to the histological analysis of the Plvap−/− testis at five weeks of age, 
most of the seminiferous tubule epithelia were found to exhibit incomplete 
spermatogenesis, lacking the ES layer. Thus, to evaluate whether hormonal therapy 
induces the completion of spermatogenesis in the Plvap−/− testis, we performed 
immunofluorescence staining with rhodamine-labeled peanut agglutinin, which 
stains the acrosome in RSs and ESs. Immunofluorescence staining showed that the 
phenotype of the hCG-treated Plvap−/− testis was partially recovered. Moreover, 
peanut agglutinin staining showed an increased number of RSs and ESs in the 
seminiferous epithelium of hCG-treated Plvap−/− mice in comparison to untreated 
Plvap−/− mice (IV; Figure 10A). Quantification of the seminiferous tubules 
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exhibiting complete spermatogenesis or lacking one more layer of RSs or ESs was 
also was performed. The results show that hCG-treated Plvap−/− mice displayed a 
significantly increased number of tubules exhibiting complete spermatogenesis and 
a significantly decreased number of tubules lacking an ES layer in comparison to 
untreated Plvap−/− mice (IV; Figure 10B). In line with the observations described 
above, hematoxylin and eosin staining of the cauda epididymis of treated-Plvap−/− 
mice showed mature spermatozoa (IV; Figure 10C). Collectively, our data show that 
the testicular phenotype of Plvap−/− mice is mainly due to the abnormal hormone 
secretion as hormonal therapy was able to partially recover the testicular phenotype 
of Plvap−/− mice. 
The failure of spermatogenesis due to low gonadotrophin levels observed in the 
Plvap−/− mice has also been reported in other gonadotrophin-related mouse models, 
in which the significantly low androgen levels affect spermatogenesis. For example, 
in LH-receptor-deficient mice (LuRKO mice), the ITT levels were found to be 
significantly lower and the FSH levels were found to be two times higher than in the 
control mice. Notably, the testes of young adult LuRKO mice have the same size 
and weight and exhibit narrow seminiferous tubules and spermatogenic arrest as 
those of Plvap−/− mice 135. However, the low but detectable ITT levels in LuRKO 
mice do not completely halt spermatogenesis but rather delay the spermatogenic 
cycle. Despite the very low ITT levels in the testes of LuRKO mice, the testes of 12-
month-old mutant mice display complete spermatogenesis 249. Therefore, it is 
important to assess the ITT levels in Plvap−/− testes and whether those levels can 
maintain spermatogenesis in Plvap−/− testes at an older age, similar to LuRKO mice. 
In FSHR- 239 or FSHβ-deficient (FSHβR) 240 mice, spermatogenesis is normal and 
the mice are fertile. However, the testis size and the diameter of the seminiferous 
tubules are significantly reduced as a result of abnormal SC proliferation during the 
pubertal age. On the basis of these phenotypes, the abnormal proliferation dynamics 
of SCs in Plvap−/− testes may be explained by the significantly reduced levels of FSH 
in serum, which lowers the proliferation of SCs at the pubertal age and, 
consequently, results in a small testis size at the age of five weeks. 
It has been shown that PLVAP controls the seeding of fetal liver-derived 
macrophages and that Plvap−/− mice have a diminished population of these 
macrophages in the spleen, peritoneal cavity, mammary glands, and lungs 10,250. 
Besides, it has previously been reported that testicular macrophages regulate the 
development and function of Leydig cells 241,242. In our study, we did not examine 
the testicular macrophage composition in Plvap−/−. Hence, it is important to verify 
whether Plvap−/− testes lack this specific macrophage population. If this is the case, 
then the Plvap−/− mouse line would be a unique model to study the role of this specific 
macrophage population in the testicular function. 
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5.4.5 Future perspectives (IV) 
To our knowledge, this is the first study describing the role of PLVAP in the 
endocrine regulation of the testis. Since the hCG treatment was able to partially 
recover the phenotype of the Plvap−/− testis, we concluded that the gonadotropin 
insufficiency is the main cause of the spermatogenesis failure. However, since a 
global Plvap knockout model was used, indirect factors such as leakage of plasma 
proteins into the testis, may also contribute to the Plvap−/− testis dysfunction. 
Interestingly, as the pituitary of Plvap−/− mice also displays low levels of LH and 
FSH, the Plvap deficiency has evident impact on the gonadotropin production. 
Further studies are needed to determine the impact of the Plvap deficiency on the 
pituitary development and function. 
It has been proposed that PLVAP is a potential therapeutic target for some forms 
of cancer treatment as it decreases tumor growth and has minor systemic toxicity 200. 
However, in this study, we have shown that the loss of PLVAP also has adverse 
effects on the endocrine regulation of the testis. Thus, further studies on 
characterizing the effect of the partial loss of Plvap need to be performed. 
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6 Conclusions 
Collectively, the results of this thesis study addressed the role of selected proteins in 
controlling specific events during testicular development and spermatogenesis. We 
also developed a flow-cytometry-based method for the study of testis composition. 
This study contributes with key information for a better understanding of the 
molecular processes that affect male fertility and reproduction.  
 
The main findings of the studies performed herein are as follows: 
 
I. The flow cytometry protocol established in this study is a great tool for 
studying rodent testicular cell composition. Moreover, this protocol is 
very advantageous because multiple intracellular markers can be used and 
samples can be stored and delivered to other laboratories. 
II. USF1 is a transcription factor involved in maintaining the balance 
between spermatogonial cell renewal and differentiation in the mouse 
testis. 
III. Both RB and the transcription factor E2F3 are implicated in the 
maintenance of adult SCs in a quiescent state. 
IV. PLVAP contributes indirectly to normal testicular development and 
function by influencing the endocrine regulation of the testis. 
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